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ABSTRACT 
Fishbein, Cassandra R. DNP.  Miami Valley-College of Nursing and Health, Wright 
State University/University of Toledo, 2017.  Screening Mothers for Postpartum 
Depression at Well-Child Visits in a Private Pediatric Clinic: An Evidence-Based 
Practice Improvement Project. 
 
Postpartum depression (PPD) affects approximately 10-15% of women and can have 
serious negative effects on mothers, infants, and families.  PPD can persist throughout 
the first year after delivery when mothers no longer have consistent contact with their 
primary health care provider.  The U.S. Preventive Services Task Force, the American 
Congress of Obstetricians and Gynecologists, the American Academy of Family 
Physicians, and the American Academy of Pediatrics recommend screening for 
depression when support systems are in place to ensure referral for further evaluation, 
diagnosis, and treatment.  Pediatric providers have consistent interactions with 
mothers and infants during well-child visits.  During this evidence based practice 
improvement project, a screening program for depression was implemented using the 
Edinburgh Postnatal Depression Scale (EPDS) at the 2 week, 2 month, 4 month, 6 
month, well-child visits.  Mothers who screened positive were provided community 
resources and referred to their primary care provider.  The Evidence-Based Practice 
Improvement Model (EBPI) guided this project.  Eight pediatric providers, seven 
licensed practical nurses (LPN), two receptionists, and the office manager were 
educated on the significance and risks of PPD, the effectiveness of PPD screening, the 
use of the EPDS, and steps to take when the screening indicated a risk for PPD was 
present.  A total of 255 mothers were eligible for screening and 160 mothers (67%) 
completed the EPDS during the three month implementation period.  Documentation 
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of the screening and distribution of resource packets and referrals given to mothers 
occurred at a nearly 100% rate.  In addition, demographic information including 
mother’s age, mother’s race, marital status, age of infant, gestational age of infant, 
method of feeding, and type of insurance was also collected. Providers, staff, and 
patients in this clinic benefited from education on PPD and screening continues to be 
included in the selected well-child visits.  Implementation of PPD screening in other 
settings is indicated to demonstrate the effectiveness of identifying mothers with PPD.   
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I. INTRODUCTION 
Problem  
Postpartum depression (PPD) is a serious complication with significant 
adverse effects on maternal bonding, the emotional and behavioral development of 
infants, and parenting (Olson, Dietrich, Prazar & Hurley, 2006).  It is estimated that 
10% to 15% of women suffer from PPD and their symptoms often occur after hospital 
discharge and when they are no longer being seen by their healthcare provider 
(Liberto, 2012).  Apter-Levy, Feldman, Vakart, Ebstein, and Feldman (2013) explain 
that longitudinal studies have revealed that children whose mothers are diagnosed 
with PPD are at greater risk for anxiety, depressive and oppositional conduct 
disorders, as well as maladaptive social behavior.  In a study conducted by Quevedo 
et al. (2011) infants of mothers with persistent depression had lower scores on 
language scales at 12 months of age compared to infants whose mothers did not have 
depression.  The serious negative effects on mothers and infants necessitate the 
crucial need for early recognition and treatment of PPD.  Chaudron, Szilagyi, 
Kitzman, Wadkins, and Cornwell (2004) assert that the only regular health care 
contact by new mothers is during well-child visits.  In fact, if all recommended well 
child visits are completed the new mother will have contact with a pediatric health 
care professional at least eight times in the child’s first two years (Liberto, 2012).  
Maternal depression is a term that includes a spectrum of depressive 
symptoms that can affect mothers-to-be and mothers up to 12 months postpartum. 
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This includes prenatal depression, “baby blues,” postpartum depression, and 
postpartum psychosis.  
Prenatal depression can occur any time during pregnancy and can affect 10 to 
20% of expectant mothers.  It can persist for six to 12 months after pregnancy and 
includes symptoms such as anxiety, fatigue, sleep disturbances, changes in appetite, 
and irritability (National Institute for Healthcare Management, 2010).   
Pregnancy, labor and delivery, and caring for a newborn can be physically, 
mentally, and emotionally draining experiences for women.  As many as 80% of new 
mothers’ experience what is referred to as “baby blues” or “postpartum blues” with 
symptoms including crying, sadness, anxiety, irritability, insomnia, and mood lability 
(National Institute for Healthcare Management, 2010).   
Postpartum depression affects between 10 to 15% of new mothers and can 
initially be indistinguishable from “baby blues.”  It typically manifests within the first 
two to three months postpartum and symptoms may include persistent sadness, poor 
concentration, feelings of worthlessness and guilt, irritability, anhedonia, fatigue, 
insomnia or hypersomnia, somatic symptoms, poor bonding with the infant, and 
recurrent thoughts of death or suicide (National Institute for Healthcare Management, 
2010).   
Postpartum psychosis occurs much less frequently affecting one to two out of 
1,000 mothers.  It most often manifests in the first two to four weeks after delivery but 
can occur any time during the first year.  Symptoms include auditory and visual 
hallucinations, paranoia, anxiety, agitation, insomnia, mania, suicidal or homicidal 
thoughts, and bizarre delusions or commands to harm the infant (National Institute for 
Healthcare Management, 2010).  Table 1 provides a comparison of postpartum blues, 
postpartum depression and postpartum psychosis.  
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Table 1 
 
Postpartum Blues, Postpartum Depression and Postpartum Psychosis Symptom 
Comparison 
Postpartum Blues Postpartum Depression Postpartum Psychosis 
 
Affects up 80% of new 
mothers 
Affects between 10-15% 
of new mothers 
Affects one to two out of 
1,000 new mothers 
Crying Persistent sadness Auditory and visual 
hallucinations 
Sadness Poor concentration Paranoia 
Anxiety Feelings of worthlessness 
and guilt 
Anxiety 
Irritability Irritability Agitation 
Insomnia Anhedonia Insomnia 
Mood lability Fatigue Mania 
 Insomnia Suicidal or homicidal 
thoughts 
 Hypersomnia Bizarre delusions or 
commands to harm the 
infant 
 Somatic symptoms  
 Poor bonding with infant  
 Recurrent thoughts of 
death or suicide 
 
(National Institute for Healthcare Management, 2010) 
In addition to the psychological burden of PPD there is also a financial burden. 
Although the precise cost of PPD in the United States is not known, the overall cost of 
depression among the entire population is significant.  In 2000, the total cost for 
depression was $83.1 billion dollars.  This includes $26.1 billion for direct medical 
costs, $5.4 billion for suicide-related mortality costs and $51.5 billion for associated 
workplace costs (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015).  In addition, 
the children of mothers with postpartum depression utilize health care services more 
frequently adding additional costs to the health care system (National Institute of 
Health Care Management, 2010).  Identification of PPD and referral to appropriate 
resources has the potential to improve the health and quality of life for mothers, 
children, and their families while also reducing the cost of depression on society. 
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 The U.S. Preventive Services Task Force (2015) recommends screening all 
adults for depression when support systems are in place to ensure referral for further 
evaluation, diagnosis, and treatment.  Both the American Congress of Obstetricians 
and Gynecologists (2015) and the American Academy of Pediatrics (2010) have 
issued position statements and recommendations for screening women for postpartum 
depression that are consistent with the U.S. Preventive Services recommendations.  
 Data for Ohio collected through the Pregnancy Risk Assessment Monitoring 
System (PRAMS) in 2009-2011, shows that 12. 4% of mothers in Ohio experienced 
symptoms of PPD while 11.5% of mothers in the Dayton area experienced these 
symptoms (Ohio Department of Health, 2015).   
 The negative effects of PPD for mothers, neonates, infants, and families is 
well-documented. Symptoms of PPD can present at any time during the first year after 
delivery.  Postpartum mothers and their infants have frequent contact with pediatric 
providers at well-child visits within the first year of life.  One plausible solution for 
early identification of PPD is to screen for PPD at well-child visits with subsequent 
referral of mothers to the appropriate level of care.  
Purpose and Goals 
 To address this clinical problem and to guide the search for relevant 
information, a PICOT question was developed.  A well-developed PICOT (Patient 
population, Intervention, Comparison intervention, Outcome, and Time) question 
assists in guiding the literature search to obtain the most relevant information 
(Fineout-Overholt & Stillwell, 2015).  The question used to guide the literature search 
was “In postpartum mothers who bring neonates and infants for well-child visits 
during the first year after delivery, how does postpartum depression screening by 
pediatric health care providers compared to no screening affect identification of PPD 
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and provision of community resources and referrals to the mother’s primary care 
provider over a 3-month period.” A neonate is defined as a child under 28 days of age 
(World Health Organization, 2016) and an infant is a child up to one year of age 
(Centers for Disease Control and Prevention, 2016).  The American Academy of 
Pediatrics (2016) recommends well-child checks for neonates and infants at three to 
five days, two weeks, two months, four months, six months, nine months and 12 
months of age. 
 The purpose of this evidence-based improvement project was to implement a 
PPD screening program for mothers who bring their infants for well-child visits, 
during the first year of life, at a private pediatric practice.  The goals of the project 
included identifying mothers at risk for PPD and providing them with community 
resources and referrals to their primary care provider for further evaluation and 
treatment.   
Guiding Framework 
The model selected to guide this project was the Evidence-Based Practice 
Improvement (EBPI) model presented by Levin et al. (2010).  A unique characteristic 
of this model is that it combines two existing models, evidence-based practice (EBP) 
and performance or practice improvement (PI).  Each of these models has been used 
in health care to implement quality improvement and EBP projects.  The EBPI model 
focuses on formulating a precise clinical question which guides the review of the 
research literature, and then critical appraisal of the evidence based on its level, 
quality and significance towards a practice change.  Designing and implementing the 
practice change; implementing, testing and evaluating the change; and finally, 
disseminating the results of the change is the focus of the PI model.  In combining 
these two practices, EBPI provides practitioners with a practical model which guides 
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a project from describing the problem and formulating the clinical question to the 
dissemination of the results.    
The seven steps of the EBPI model include: describe the problem, formulate 
focused clinical question, search for evidence, appraise and synthesize evidence, 
develop aim (goal) statement, plan-do-study-act cycles, and disseminate best practices 
(Levin et al., 2010).  The problem identified for this project was postpartum 
depression (PPD) and the potential negative effects on infant development. 
Identification of the problem led to development of the PICOT question, a search for 
relevant evidence and an appraisal and synthesis of the literature.  The model guided 
development of an aim statement, plan-do-study-act cycles and dissemination of best 
practices throughout the project.  
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II. EVIDENCE 
Search for Evidence 
 Databases searched for relevant literature in answering the PICOT question 
include The Cochrane Library, CINAHL and MEDLINE via PubMed.  The key words 
“postpartum depression”, “post partum depression”, “postnatal depression”, “post 
natal depression”, “screen”, “screening”, “diagnose”, “diagnosis”, “diagnoses”, 
“nursing”, “nurse”, “physician”, “clinician”, “pediatric”, “paediatric”, “provider”, 
“health professional”, “healthcare professional”, and “health care professional” were 
used when searching the databases.  Criteria for inclusion were systematic reviews, 
meta-analysis, randomized controlled trials and any other quantitative or qualitative 
research designs, in English, published in the past 15 years.  Research that considered 
women during the first year after giving birth was also included.  Criteria for 
exclusion was research that studied women with other psychological disorders or in 
high-risk situations, foreign-born postpartum women in the United States and 
postpartum women with infants diagnosed with high-risk conditions.  Practice 
recommendations from professional organizations as well as clinical practice 
guidelines were also included.   
 Results from the search of The Cochrane Library resulted in seven hits, none 
of which met the inclusion criteria.  There were eight hits in the Database of Abstracts 
of Reviews and one article which met the inclusion criteria. 
 CINAHL was first searched with the key words “postpartum depression”, 
“post partum depression”, “postnatal depression” and “post natal depression” which 
resulted in 4,035 hits.  Keywords searched next were “screen”, “screening”,  
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“diagnose”, “diagnosis”, and “diagnoses” which resulted in 490,285 hits.  The final 
set of keywords searched were “nursing”, “nurse”, “physician”, “clinician”, 
“pediatric”, “paediatric”, “provider”, “health professional”, “healthcare professional” 
and “health care professional” which resulted in 699,321 hits.  Combining the three 
searches and applying the limits of English language and research article resulted in 
108 hits, of which 15 articles met the inclusion criteria.  Controlled vocabulary was 
not used in this search.   
 MEDLINE via PubMed was first searched with the key words “postpartum 
depression”, “post partum depression”, “postnatal depression” and “post natal 
depression” which resulted in 6,624 hits.  Keywords searched next were “screen”, 
“screening”, “diagnose”, “diagnosis”, and “diagnoses” which resulted in 8,540,397 
hits.  The final set of keywords searched were “nursing”, “nurse”, “physician”, 
“clinician”, “pediatric”, “paediatric”, “provider”, “health professional”, “healthcare 
professional” and “health care professional” which resulted in 1,767,051 hits.  
Combining the three searches and applying the limits of English language, systematic 
reviews, meta-analysis and randomized controlled trial resulted in 163 hits, of which 7 
articles met the inclusion criteria.  Controlled vocabulary was not used in this search.   
 The search of these databases resulted in the inclusion of 23 articles for 
evaluation and critical appraisal.  A review of the 23 articles revealed one article was 
a repeat, two articles only addressed PPD screening in the two to three days after birth 
and two articles did not assess postpartum women at well-child visits.  Ultimately 17 
articles were included in this review. 
 In addition, a search for clinical practice guidelines and recommendations 
from relevant professional organizations was also conducted.  The U.S. Preventive 
Services Task Force (USPSTF) updated its recommendations for screening for 
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depression in January 2016.  The current recommendation is to screen for depression 
in the general adult population, including pregnant and postpartum women.  This 
recommendation applies to adults 18 years and older with implementation when 
systems are in place to ensure adequate follow-up (Siu, 2016).  The American 
Academy of Family Physicians, the American College of Obstetricians and 
Gynecologists, and the American Academy of Pediatrics have issued position 
statements which address screening mothers for postpartum depression.  The 
American Academy of Family Physicians recommends screening for depression in the 
general adult population, as well as pregnant and postpartum women.  The American 
College of Obstetricians and Gynecologists recommend screening patients at least 
once during the perinatal period for depression and anxiety and the American 
Academy of Pediatrics recommends that mothers be screened for depression at the 
two week, two month, four month and six month well-child visits (Siu, 2016).  
Appraisal and Synthesis of the Evidence 
While the prospect of appraising evidence obtained from a search of the 
literature may seem daunting, Melnyk and Fineout-Overholt (2015) describe three key 
questions to guide the initial evaluation of evidence.  These questions address the 
validity, reliability, and applicability of the literature to the posed clinical question.  
After the literature is selected, it is important to establish the level of evidence.  The 
rating system presented by Fineout-Overholt and Stillwell (2015) was used for this 
purpose.  In this method, the literature is evaluated and assigned a level as follows: 
Level I; systematic review or meta-analysis of randomized control trials, Level II; 
randomized control trials, Level III; control trials without randomization, Level IV; 
case control and cohort studies, Level V; systematic reviews of descriptive and 
qualitative studies, Level VI; descriptive or qualitative studies, and Level VII; expert 
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opinion or expert committee reports.  During the review of literature, no level I 
systematic review, which addressed the PICOT question, was found.  Two Level II 
randomized control trials, two Level IV cohort studies, two Level V systematic 
reviews of quantitative and qualitative studies, and 11 Level VI single descriptive or 
qualitative studies were found to be relevant in answering the PICOT question.   
 Identification of the level of evidence is an important first step in appraisal of 
the literature, however this information alone is inadequate in establishing the 
potential value or harm of an intervention.  Guyatt et al. (2008a) assert that 
“insufficient attention to quality of evidence risks inappropriate guidelines that may 
lead clinicians to act to the detriment of their patients” (p. 925).  For the purpose of 
evaluating the quality of the evidence and determining the strength of 
recommendation for a practice change, the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) was used (Guyatt et al., 2008b).   
 The Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) working group provides clear and comprehensive methods for the 
subjective rating of evidence and offers four levels of quality: high, moderate, low, 
and very low.  The GRADE approach considers the highest quality of evidence to be 
randomized trials and the lowest quality of evidence to be observational studies.  The 
system identifies five factors which can decrease the quality of the evidence: study 
limitations, inconsistency of results, indirectness of evidence, imprecision, and 
publication bias.  Three factors are identified which may increase the quality of the 
evidence: large magnitude of effect, plausible confounding, and dose-response 
gradient (Guyatt et al., 2008c).  Although lower level evidence, such as observational 
studies, may initially receive a lower rating in this system, the GRADE approach 
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includes the importance for this type of evidence in determining recommendations 
when the evidence has a large treatment effect (Guyatt et al., 2008c).  
 In addition, GRADE provides guidance in the determination of a 
recommendation for a change in practice.  GRADE has two categories for 
recommendations: strong and weak.  The strength of the recommendation is  
determined by the quality of evidence, the balance between desirable and undesirable 
effects, values and preferences, and costs (Guyatt et al., 2008b).  For example, if the 
quality of the evidence is moderate or low but the effects of the intervention are 
highly desirable and risks of the intervention are minimal then a strong 
recommendation may be offered.   
 Four themes emerged from a review of the literature related to the PICOT 
question: (a) persistence of PPD beyond the immediate postpartum period, (b) 
pediatric providers’ belief that it is their responsibility to assess mothers for PPD, (c) 
acceptability of screening for PPD during well child visits by pediatric providers and 
mothers, and (d) effectiveness of screening for PPD during well child visits.  
Persistence of Postpartum Depression.  In a study conducted by Chaudron, 
Kitzman, Szilagyi, Sidora-Arcoleo and Anson (2006) findings show that of 67 women 
assessed for PPD at well child visits 33% reported high symptom levels during the 
first year, 26% developed high symptom levels after the first 3 months, and 41% 
showed improvement in symptoms after three months.  In an integrated review, 
Liberto (2012) reports that PPD affects 10 to 15% of postpartum women.  This is a 
significant cause for concern since PPD is known to have adverse effects on child 
development and women’s interaction with their provider ends shortly after birth.  
Stowe, Hostetter and Newport (2005) report that 11.5% of women experience prenatal 
onset of depressive symptoms, 22.0% experience late onset postpartum symptoms and 
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66.5% experience an early onset of postpartum symptoms.  Table 2 displays the 
evaluation of the literature regarding the persistence of postpartum depression.  
 Pediatric Providers’ Beliefs.  In a cross-sectional survey of United States 
primary care pediatricians, Olson et al. (2002) report that 54% of providers believe it 
is their responsibility to recognize PPD in mothers.  These providers also identified 
lack of time and training in screening for PPD as barriers.  Leiferman, Dauber, Heisler 
and Paulson (2008) surveyed obstetricians, pediatricians and family medicine 
practitioners.  All specialty providers believed that it was their responsibility to screen 
for PPD.  Among this group of providers, pediatricians reported being the least 
comfortable with screening and discussing PPD.  In a study by Heneghan, Morton and 
DeLeone (2007) all pediatricians believed that it was appropriate to ask mothers about 
their health during well-child visits.  These providers reported that they relied on 
observational cues to identify PPD, rarely used screening tools, and noted time as a 
barrier in identifying PPD.  Goldsmith (2007) explored PPD screening behaviors of 
family nurse practitioners and found that of those who saw postpartum women 42% 
never screened for PPD.  The single biggest predictor of screening behavior in this 
group was confidence in how to use a screening tool.  Mason and Poole (2008) 
interviewed health care professionals who used the Edinburgh Postnatal Depression 
Scale (EPDS) to screen for PPD.  These providers had positive views on using this 
screening tool and believed it was a useful tool in opening a dialogue about PPD.  
However, they did express concern about the question regarding self-harm and its 
potential to offend some mothers.  Santos, Gualda, Silveira and Hall (2013) studied 
the attitudes of Brazilian physicians and nurses regarding screening for PPD and 
found these professionals did not believe it was their responsibility to screen for PPD 
and that depression was the domain of psychiatry.  
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Table 2 
 
Persistence of Postpartum Depression 
Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Chaudron, L.H., 
Kitzman, H.J., 
Szilagyi, P.G., 
Sidora-Arcoleo, 
K. & Anson, E. 
(2006). Changes 
in maternal 
depressive 
symptoms across 
the postpartum 
year at well child 
care visits. 
Ambulatory 
Pediatrics, 6, 
221-224.    
 
Design: 
- Descriptive 
 
Method: 
- Retrospective 
review of data 
obtained from a 
prior study of 
postpartum 
depressive 
symptoms among 
mothers who 
brought their 
child to well child 
care visits in the 
year after birth 
and completed 
the Edinburgh 
Postnatal 
Depression Scale 
(EPDS) 
 
N = 67 
Subjects whose 
record included two 
or more completed 
EPDS forms 
 
- Data collected 
from large pediatric 
practice affiliated 
with a university 
medical center in a 
large city 
 
 
-Edinburgh Postnatal 
Depression Scale 
(EPDS) a 10-item, 
self-administered 
questionnaire 
- Developed as a 
screening tool (not 
diagnostic) to assess 
depressive symptoms 
in women who have 
given birth recently 
- Validated in many 
settings and in large 
samples 
- Sensitivity of 93% 
and specificity of 83% 
at 6 to 8 weeks 
postpartum for a score 
> or = 10 for major 
depression  
- Cutoff score of 10 
was used to indicate 
clinically significant 
symptoms for this 
study 
 
 
- Proportions were 
calculated for 
changes in 
depressive 
symptom 
categories from 
early to late 
postpartum 
- The highest 
score in early and 
late postpartum 
was used to 
describe changes 
in symptoms 
 
For women who 
completed the 
EPDS at least 
once before 3 
months and 
between 3 and 
11 months 
postpartum, 
33% were 
identified with 
high symptom 
levels 
throughout the 
year, 41% 
improved after 
the first 3 
months and 
26% developed 
high symptom 
levels after the 
first 3 months 
 
Level VI Moderate 
 
 
1
4
 
 
Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Liberto, T.L. 
(2012). Screening 
for depression 
and help-seeking 
in postpartum 
women during 
well-baby 
pediatric visits: 
An integrated 
review. Journal 
of Pediatric 
Health Care, 
26(2), 109-117.    
 
Design: 
- Integrated 
review of 
literature from 
qualitative, 
quantitative and 
mixed method 
research  
 
Method: 
- Systematic 
review of 
literature of 
English language 
research  
-Used Academic 
Search Premier, 
CINAHL, 
MEDLINE, 
Mental 
Measurements 
Yearbook, 
PsycINFO, 
PsycARTICLES, 
and Women’s 
Studies 
International  
 
Primary source 
documents 
published from 
1995 to 2009 
 
Keywords 
searched: 
postpartum, 
postpartum 
depression, help 
seeking, and 
pediatric 
setting/pediatrician 
311 studies were 
assessed for 
eligibility. Thirty-
five studies met the 
criteria.  
 
-Integrated review 
methodology by 
Whittemore and Knafl 
provides a framework 
to guide the integrated 
review process to 
enhance the rigor of 
the review 
 
- Each article was 
evaluated for 
issues related to 
specifying the 
review purpose, 
searching the 
literature, 
evaluating data 
from primary 
sources, analyzing 
data and 
presenting results 
 
- Postpartum 
Depression 
(PPD) affects 
10%-15% of all 
women after 
birth 
- Women with 
PPD generally 
do not seek help 
for depression 
- Untreated PPD 
has significant 
adverse effects 
on maternal 
bonding, 
parenting and 
the infant’s 
development 
- Womens’ 
interaction with 
their obstetric 
provider ends 
shortly after 
birth 
- Frequent 
interactions 
with the 
pediatric office 
continue 
throughout the 
child’s first two 
years of life. 
Level V Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Stowe, Z., 
Hostetter, A.L. 
& Newport, D.J. 
(2005). The 
onset of 
postpartum 
depression: 
Implications for 
clinical 
screening in 
obstetrical and 
primary care. 
American 
Journal of 
Obstetrics and 
Gynecology, 
192(2), 522-526.   
 
Design: 
- descriptive  
 
Method: 
- Women 
referred to a 
women’s mental 
health program 
for evaluation of 
postpartum 
depression 
 
- Descriptive 
analysis was 
conducted for 3 
participant 
groups: 
pregnancy onset, 
early postpartum 
onset within 6 
weeks of 
delivery and late 
postpartum onset 
 
n = 209 
Women included 
fulfilled criteria 
for major 
depression and 
were not taking 
psychotropic 
medication 
 
At presentation, 
women completed the 
Edinburgh Postnatal 
Depression Scale, 
Beck Depression 
Inventory and an 
intake questionnaire  
 
Time of illness was 
defined as the 
beginning of the 
current major 
depressive episode 
 
-Frequency tests 
for categorical 
data and analysis 
of variance with 
post hoc Tukey-
Kramer multiple 
pairwise 
comparison tests 
for continuous 
data 
 
-Among 
participants, 
11.5% reported 
prenatal onset, 
22.0% late 
postpartum 
onset and 
66.5% early 
postpartum 
onset 
- Those 
reporting 
pregnancy 
onset were 
likely to be 
unmarried and 
those with late 
postpartum 
onset were 
likely to report 
a previous 
history of 
postpartum 
depression 
Level VI  Moderate 
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Table 3 demonstrates evaluation of the literature regarding pediatric providers’ beliefs 
for screening for PPD at well-child visits. 
 Acceptability of Screening.  In a systematic review, Brealey, Hewitt, Green, 
Morrell and Gilbody (2010) found that screening for PPD was acceptable to women 
and healthcare providers.  However, both groups reported that advance notice of 
screening was preferable and there was concern over the self-harm question contained 
in the EPDS.  Both groups also felt it was important to discuss the results of the 
screen during a visit.  Gjerdingen, Crow, McGovern, Miner and Center (2009) found 
women were more likely to complete PPD screening at pediatric clinics than at family 
medicine clinics.  In a study by Olson, Dietrich, Prazar and Hurley (2006), mothers 
and healthcare providers found that screening for PPD was acceptable and that it took 
less than three minutes to discuss screening results.  Walker, Eun-Ok and Tyler 
(2013) report that 85% of the women surveyed in their study found it acceptable to 
discuss maternal health needs at pediatric visits.  This rate was consistent across races 
and income levels.  Byatt, Biebel, Friedman, Debordes-Jackson and Ziedonis (2013) 
identified barriers and facilitators for women being screened for PPD in the pediatric 
setting.  Barriers included fear of stigma and loss of parental rights with a positive 
screen and ambivalence about pediatric providers conducting the screening.  
Facilitators included appreciation of addressing the medical and mental health needs 
of mother and baby and that this approach to screening was de-stigmatizing since it 
was universal.  Table 4 displays the evaluation of the literature regarding the 
acceptability of screening for PPD by mothers. 
 Effectiveness of Screening.  In a study comparing automated screening to 
reminders to screen for PPD during well-child checks, Carroll, Biondich, Anand, 
Dugan and Downs (2013) demonstrated that automated screening resulted in  
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Table 3 
 
Pediatric Providers’ Beliefs 
Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Olson, A.L., 
Kemper, K.J., 
Kelleher, K.J., 
Hammond, C.S., 
Zuckerman, B.S. 
& Dietrich, A.J. 
(2002). Primary 
care 
pediatricians’ 
roles and 
perceived 
responsibilities 
in the 
identification and 
management of 
maternal 
depression. 
Pediatrics, 
110(6), 1169-
1176. 
 
Design: 
- descriptive (cross-
sectional survey) 
 
Method: 
- National survey of 
randomly selected 
primary care 
pediatricians 
 
n = 508 
Primary care 
pediatricians 
randomly 
selected from the 
American 
Academy of 
Pediatrics 
member list 
(excluding 
resident, 
emeritus and 
subspecialty 
members) 
 
45-item 
questionnaire 
adapted for 
pediatricians from 
an adult primary 
care provider 
survey of 
depression 
management 
 
Questionnaire asked 
about the last 
recalled case of 
postpartum or other 
maternal 
depression, barriers 
to care, attitudes 
about recognition 
and management, 
confidence in skills 
and willingness to 
implement new 
strategies to 
improve care 
 
Development and 
piloting previously 
described 
-X2 and Fisher 
exact test for 
categorical 
variables 
 
P < .01 due to the 
use of multiple 
comparisons 
 
-57% of 
pediatricians 
believed it was 
their responsibility 
to recognize 
maternal 
depression 
-32% reported 
discussion using 
the term 
depression, 40% 
discussed without 
the term and 28% 
did not discuss at 
all 
- Lack of time 
(73%) and 
inadequate 
training (64%) 
were the greatest 
barriers identified 
-28% of 
pediatricians 
would consider 
changing their 
approach with 
maternal 
depression 
Level VI Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Leiferman, J.A., 
Dauber, S.E., 
Heisler, K. & 
Paulson, J.F. 
(2008). Primary 
care physicians’ 
beliefs and 
practices toward 
maternal 
depression. 
Journal of 
Women’s 
Health, 17(7), 
1143-1150.      
 
Design: 
- descriptive 
 
Method: 
- PCPs 
(obstetricians, 
pediatricians and 
family medicine 
practitioners) 
completed a 60-
item survey, by 
either web or mail.  
 
N = 217 
PCPs: 
obstetricians 
(22.6%), 
pediatricians 
(37.3%) and 
family medicine 
practitioners 
40.1%) 
 
- rural, mid-
Atlantic state in 
the United 
States 
 
-Survey developed 
in 2006 to assess 
PCPs’ attitudes, 
beliefs and 
practices regarding 
the assessment and 
treatment of 
maternal 
depression 
- Initial pool of 
items was 
developed based 
on literature review 
and physician 
interviews 
-Item set was 
narrowed and 
content validity 
was assessed by a 
panel of PCPs 
from the relevant 
specialties 
-Survey was pilot-
tested by another 
group of PCPs 
 
 
 
 
-SPSS version 
14 
- Chi-square and 
one-way 
ANOVAs 
analyses of 
survey items  
 
 
-Across 
specialties PCPs 
believed it was 
their 
responsibility to 
recognize 
maternal 
depression 
-Pediatricians 
were least 
comfortable 
discussing 
depression 
symptoms, less 
familiar with 
DSM-IV criteria 
for depression 
and less confident 
to diagnose and 
treat maternal 
depression (p < 
.001) 
 
Level VI Low 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Heneghan, 
A.M., Morton, 
S. & DeLeone, 
N.L. (2007). 
Paediatricians’ 
attitudes about 
discussing 
maternal 
depression 
during a 
paediatric 
primary care 
visit. Child: 
Care, Health and 
Development, 
33(3), 333-339.    
 
Design: 
- qualitative 
 
Method: 
- In-depth 
telephone 
interviews, each 
lasting 
approximately 30 
minutes 
-Question were 
developed based on 
similar, field-tested 
questions that were 
used for maternal 
focus groups 
 
n = 23 
Pediatricians 
practicing in a 
practice-based 
research 
network  
 
- Large urban 
area 
 
 
-10 interview 
questions 
developed a priori 
to elicit 
pediatricians’ 
perceptions and 
attitudes about 
discussing 
maternal 
depressive 
symptoms in the 
context of a 
pediatric primary 
care visit 
 
- Researcher 
experienced in 
coding an 
analyzing 
qualitative data 
oversaw all data 
analyses.  
- Immersion and 
crystallization 
techniques  
- Codebook was 
created and 
responses were 
coded in a 
question-by-
question order, 
including noted 
non-verbal 
responses 
-All study 
investigators 
reviewed and 
coded transcripts 
-All pediatricians 
agreed it is 
appropriate to ask 
mothers about 
their health 
during well-child 
visits 
- Pediatricians 
rely on 
observational 
cues, especially 
mother-child 
interactions 
- Few used direct 
questions or a 
checklist 
- Lack of time 
was the greatest 
barrier identified 
- One-third of 
pediatricians 
expressed the fear 
of judgment and 
stigma that a 
mother may face 
when discussing 
maternal stresses 
 
 
Level VI Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Goldsmith, M.E. 
(2007). 
Postpartum 
depression 
screening by 
family nurse 
practitioners. 
Journal of the 
American 
Academy of 
Nurse 
Practitioners, 
19(6), 321-327.     
 
 
Design: 
- Descriptive, 
nonexperimental 
survey design 
 
Method: 
- Self-report data 
collected via a 
questionnaire 
mailed to family 
nurse practitioners 
(FNPs) who were 
members of the 
American Academy 
of Nurse 
Practitioners 
(AANP) residing in 
Illinois or 
Wisconsin 
 
N = 159 
 
- FNPs were 
chosen as the 
focus of the 
investigation 
because they are 
most likely to 
encounter 
postpartum 
women in a 
variety of 
settings: 
pediatrics, 
women’s health 
or internal 
medicine 
 
-Questionnaire for 
the study was 
developed by the 
author 
- 15 questions, 4 
pages and 
approximately 10 
minutes to 
complete 
- Used to collect 
data on the 
subjects’ use of 
screening tools and 
barriers to 
screening they 
encounter 
-Instrument 
underwent pilot 
testing for clarity, 
validity, and ease 
and speed of use 
among FNP and 
physician assistant 
colleagues 
 
 
 
 
 
- SPSS 
- Pearson 
product-moment 
correlations to 
determine the 
relationships 
between 
screening 
behaviors and 
characteristics of 
practice settings 
and of the 
responding FNPs 
 
- 84% of 
respondents saw 
at least one 
postpartum 
woman yearly 
- 42% never 
screened for 
postpartum 
depression  
- Subjects’ 
confidence in 
how to use a 
screening tool 
was the single 
best predictor of 
screening 
behavior (r = 
.487) 
 
Level VI Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Mason, L. & 
Poole, H. 
(2008). 
Healthcare 
professionals’ 
views of 
screening for 
postnatal 
depression. 
Community 
Practitioner, 
81(4), 30-33. 
Design: 
- Qualitative 
(phenomenological) 
 
Method: 
- Private semi-
structured 
interviews  
 
 
n = 19 
Healthcare 
professionals 
who administer 
the EPDS 
 
- one primary 
care Trust 
(PCT) in 
England 
 
 
-Private, semi-
structured 
interviews lasting 
between 25-75 
minutes 
- Interviews were 
audio recorded, 
transcribed and 
checked for 
accuracy by 
simultaneously 
listening to the 
tapes while reading 
the transcripts 
 
-Transcripts 
were 
independently 
read and re-read 
to identify 
themes and their 
interrelationships 
-Throughout 
analysis, each 
author acted as a 
check on the 
analytic account 
of the other 
author to ensure 
the developing 
analysis was 
systematic with 
results supported 
by the data 
 
-All staff were 
positive about 
using the EPDS, 
while some felt it 
was a ‘tool” to 
open up 
discussion 
- The item asking 
about self-harm 
was the most 
problematic for 
HCPs. Many 
voiced concern 
that it could 
offend some 
mothers –
Participants also 
relied on their 
experience, the 
mothers’ non-
verbal cues and 
body language 
when assessing 
for postnatal 
depression 
 
 
 
 
Level VI Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Santos, H.P. 
Gualda, D.M., 
Silveira, M.D. & 
Hall, W.A. 
(2013). 
Postpartum 
depression: The 
(in) experience 
of Brazilian 
primary 
healthcare 
professional. 
Journal of 
Advanced 
Nursing, 69(6), 
1248-1258.    
Design: 
- Qualitative 
(descriptive)  
 
Method: 
- open-ended  
interviews 
 
n=17 
Purposeful 
sample of 10 
nurses and 7 
physicians  
 
- 14 primary 
health care units 
in an urban area 
in Northeastern 
Brazil 
 
-Open-ended 
interview 
averaging 30 
minutes 
- All interviews 
were audio 
recorded, 
transcribed and 
checked for 
accuracy 
 
- Audio-recorded 
interviews were 
transcribed into 
verbatim reports 
- 3 of the 4 
authors checked 
the audiotapes 
against the 
transcriptions to 
ensure data 
accuracy 
- Interviews 
were coded line 
by line 
- Codes were 
clustered into 
categories which 
resulted in the 
development of 
themes 
 
Themes: 
- Limited 
professional 
exposure to 
postpartum 
depression 
- Postpartum 
depression as the 
domain of 
psychiatry 
- Few 
professionals felt 
postpartum 
depression 
merited their 
attention 
 
- Women with 
postpartum 
depression were 
usually identified 
by family 
members 
- Care providers 
reported 
inadequate time 
and access to 
screening 
techniques   
Level VI Moderate 
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Table 4 
 
Acceptability of Screening 
Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Brealey, S.D., 
Hewitt, C., 
Green, J.M, 
Morrell, J. & 
Gilbody, S. 
(2010). 
Screening for 
postnatal 
depression-is it 
acceptable to 
women and 
healthcare 
professionals? A 
systematic 
review and 
meta-synthesis    
Design: 
- Systematic review 
of literature from 
qualitative and 
quantitative research  
 
Method: 
- Systematic review 
of research literature 
without language or 
geographical 
restrictions 
-Used MEDLINE, 
CINAHL, 
PsychINFO, 
EMBASE, 
CENTRAL, DARE, 
CDSR, SSCI, 
Maternity and Infant 
Care, NRR, ReFeR, 
mRCT, HSRProj, 
LILACS, Inside 
Conferences and 
Dissertation Abstracts 
-All databases were 
searched from their 
inception until 
February 2007 
Articles needed 
to address the 
acceptability of 
PND screening 
during the 
prenatal and 
postnatal 
period.  
 
225 studies 
were assessed 
for eligibility. 
Sixteen studies 
met the criteria.  
 
-Edinburgh 
Postnatal 
Depression Scale 
(EPDS)-the focus of 
15 studies 
 
- Beck Depression 
Inventory 
 
- Diagnostic 
Interview Schedule 
 
- Faces 
 
- General Health 
Questionnaire-30 
 
- Postnatal 
Depression 
Screening Scale 
 
- Pregnancy 
Questionnaire 
 
- 2 independent 
reviewers 
independently 
assessed the titles 
and/or abstracts of 
the citations from 
the electronic 
searches 
- The 2 reviewers 
independently 
performed the 
extraction of data 
for a sample of 
studies each and 
one of the 
reviewers checked 
all studies 
- women liked to 
be informed in 
advance about the 
questionnaire 
- healthcare 
providers agreed 
with mothers about 
prior notification 
- women preferred 
to talk when 
completing the 
questionnaire and 
wanted feedback 
on the results 
- healthcare 
providers also 
found it useful to 
discuss results 
- the question 
about self-harm on 
the EPDS 
concerned both 
groups 
 
Level V Low 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Gjerdingen, D., 
Crow, S., 
McGovern, P., 
Miner, M. & 
Center, B. 
(2009). 
Postpartum 
depression 
screening at 
well-child visits: 
Validity of a 2-
question screen 
and the PHQ-9. 
Annals of 
Family 
Medicine, 7(1), 
63-70.     
Design: 
- Descriptive 
 
Method: 
- Mothers were 
asked to complete 
questionnaires 
during well-child 
visits at 0 to 1, 2, 4, 
6 and 9 months 
postpartum 
-Each questionnaire 
included 2 
depression screen: 
the 2-question screen 
and the PHQ-9 
-Mothers also 
initially completed 
the depression 
component of the 
Structured Clinical 
Interview for DSM-
IV (SCID) and again 
if either screening 
result was positive 
for depression 
 
n = 506 
Subjects 
represented 
approximately 
33% of the 
estimated 
eligible 
women 
(English 
literate, 12 
years of age or 
older and have 
a 0 to 1-
month-old 
infant 
 
- 7 large 
clinics from a 
large 
metropolitan 
area (4 family 
medicine 
residency 
clinics and 3 
pediatric 
private clinics 
 
 
-2-question screen 
(diminished mood 
and pleasure) 
- PHQ-9 (contains 
the DSM-IV criteria 
for major 
depressive 
disorder) 
- depression 
component of 
SCID 
- 2-question 
screen results 
were reported as 
positive if the 
respondent 
answered “yes” 
to either or both 
of the questions 
- Highest 
sensitivity 
(100%) was seen 
with the 2-
question screen 
- Highest 
specificity (94%) 
was seen with the 
PHQ-9 
 
-Results suggest 
the value of a 2-
stage procedure 
for screening for 
PPD 
- 2-question 
screen that is 
positive for 
depression is 
followed by a 
PHQ-9 
- Women enrolled 
from pediatric 
clinics were more 
likely to complete 
their 
questionnaires 
than those 
enrolled from 
family medicine 
clinics (46.3% vs 
27.2%, P = .000) 
Level VI Low 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Olson, A.L., 
Dietrich, A.J., 
Prazar, G. & 
Hurley, J. 
(2006). Brief 
maternal 
depression 
screening at 
well-child visits. 
Pediatrics, 
118(1), 207-216.   
Design: 
- cohort study 
 
Method: 
- implementation of 
brief depression 
screening of mothers 
at well-child visits 
for children of all 
ages for 1 month and 
then implemented 
again for 6 months 
 
Sample: 
- n=1,398 
Mothers 
screened at 
well-child 
visits 
 
Setting: 
- rural 
pediatric 
practices 
-Patient Health 
Questionnaire 
(PHQ)-2  
-asks the 2 USPTF-
endorsed questions 
regarding a) altered 
mood and 
anhedonia in the 
past two weeks 
PHQ-2 is derived 
from the 9-item 
Patient Health 
Questionnaire 
(PHQ-9) 
- PHQ-2 has been 
validated in both 
primary obstetric 
care and shown to 
perform as well as 
longer screening 
measures 
- It has a sensitivity 
for major 
depression of 83%, 
a specificity of 
92% and a positive 
likelihood ratio of 
2.9 
 
 
- x2 and Fisher’s 
exact test for 
categorical 
variables 
-t test and 
Pearson’s 
correlation  
 
- Screening rates 
during the initial 
1-month trial were 
74% 
- Screening rates 
during the 6 
month trial were 
67% 
-62.4% of 
providers 
discussed, 
referred and 
followed-up by 
phone when 
mothers were 
identified with 
depressive 
symptoms 
-83.5% of 
mothers who 
screened positive 
for depression 
were willing to 
take action 
-discussion of 
screening results 
required less than 
3 minutes 
(P<.001) 
Level IV Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Walker, L.O., 
Eun-Ok, I. & 
Tyler, D.O. 
(2013). Maternal 
health needs and 
interest in 
screening for 
depression and 
health behaviors 
during pediatric 
visits. Journal of 
Pediatric Health 
Care, 27(4), 
267-277.   
Design: 
- descriptive (cross-
sectional survey)  
 
Method: 
- mail survey with 
names randomly 
drawn from birth 
files 
 
 
n = 145 
Sample 
balanced for 
race/ethnicity 
and income 
level 
 
35.9% were of 
lower income 
(Medicaid 
coverage) and 
64.1% were of 
higher income 
(private 
insurance) 
 
46.2% 
White/Anglo 
25.5% African 
American 
28.3% 
Hispanic 
 
Mid size 
community in 
the southwest 
United States 
 
Survey 
questionnaire 
developed for this 
survey was based 
on the work of 
Kahn et al. 
 
 
 
-X2 for 
categorical 
variables 
 
-Almost two in 
five women 
experienced 
barriers to health 
care 
- 22% screened 
positive for 
depression and 
30% screened 
positive for 
alcohol abuse 
-Acceptability of 
discussing topics 
(depression, 
smoking and 
alcohol) at 
pediatric care 
visits was greater 
than 85% 
 
Level VI Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data Analysis Findings Level of 
Evidence 
Quality of 
Evidence 
Byatt, N. Biebel, 
K., Friedman, 
L., Debordes-
Jackson, G. & 
Ziedonis, D. 
(2013). 
Women’s 
perspectives on 
postpartum 
depression 
screening in 
pediatric 
settings: A 
preliminary 
study. Archives 
of Women’s 
Mental Health, 
15(5), 429-432.    
Design: 
- Qualitative 
(grounded theory)  
 
Method: 
- Focus groups (3) of 
women who self-
reported anxiety, 
depression in 
pregnancy or the 
postpartum period 
 
n=27 
Purposeful 
sample of 
women 3-36 
months 
postpartum  
 
- Recruited 
through a mid-
size 
community 
organization 
that provides 
education and 
advocacy for 
perinatal 
women 
 
-Focus groups 
lasted 
approximately 90 
minutes 
- All focus groups 
were audio 
recorded, 
transcribed and 
checked for 
accuracy 
 
- Nvivo software 
was used for 
analysis 
- Iterative, 
constant-
comparative 
process was used 
to review, 
segment and 
code data for 
emerging themes 
and recurrent 
patterns 
- Codes were 
added until no 
new themes 
emerged 
- Co-investigator 
and research 
coordinator had 
>90% rate of 
agreement 
 
Barriers: 
- Ambivalence 
about screening 
due to concerns 
about stigma and 
losing parental 
rights 
- Ambivalence 
about the role of 
pediatric health 
providers 
screening 
- Pediatric 
providers not 
trained to screen 
or discuss PPD 
Facilitators: 
- Addressing both 
medical and 
mental health 
needs of mother 
and baby 
- Therapeutic, de-
stigmatizing 
approach to 
screening 
Level VI High 
 
 28 
statistically significant higher rates of diagnosing maternal depression and referrals 
for treatment.  Leung, et al. (2011) evaluated the use of the EPDS at maternal child 
centers which revealed that women screened for PPD had better mental health 
outcomes at six months postpartum.  A study by Yawn, et al. (2012) implemented a 
family medicine practice-based training program for screening, diagnosis and 
management of depression in postpartum women.  Participants in the intervention 
group had higher rates of PPD identified as well as higher rates of treatment.  These 
women also had lower levels of depressive symptoms levels at six and 12 months 
postpartum.  Chaudron, Szilagyi, Kitzman, Wadkins and Conwell studied the effects 
of universal screening for PPD using the EPDS at well-child visits during the first 
year of life.  Results of this study showed a statistically significant increase in 
detecting PPD in a pediatric practice.  Table 5 displays the evaluation of the literature 
regarding the effectiveness of screening for PPD by pediatric providers. 
Screening Tools. Findings in the literature established that multiple tools are 
available and used to screen for PPD.  However, not all of the tools are designed to 
screen specifically for PPD.  The Patient Health Questionnaire-9 (PHQ-9) is a nine-
item questionnaire that is completed by the patient.  It takes five to ten minutes to 
complete and can be scored by the patient or staff (National Institute for Healthcare 
Management, 2010). The PHQ-9 has been demonstrated as a reliable and valid 
measure of depression severity in adults (Kroenke, Spitzer & Williams, 2001).  The 
Patient-Health questionnaire-2 (PHQ-2) consists of the first two questions from the 
PHQ-9 and assesses for depressed mood and anhedonia.  It takes less than one minute 
to complete and if positive is not considered diagnostic, but indicates the need for 
further evaluation (Kroenke, Spitzer & Williams, 2003).  The Beck Depression 
Inventory (BDI) is a 21-item, self-report rating inventory that assesses for the  
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Table 5 
 
Effectiveness of Screening 
Citation Design/Method Sample/Setting Outcome 
Measurement 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of 
Evidence 
Carroll, A.E., 
Biondich, P. 
Anand, V., 
Dugan, T.M. & 
Downs, S.M. 
(2013). A 
randomized 
control trial of 
screening for 
maternal 
depression with a 
clinical decision 
support system. 
Journal of the 
American 
Medical 
Informatics 
Association, 
20(2), 311-316. 
Design: 
- non-blinded, 
interventional, 
randomized control 
trial 
Method: 
- computer program 
assigned randomized 
families into 
intervention and control 
groups 
- one intervention 
group received 
screening questions for 
mothers and providers 
were alerted to positive 
screens 
- one intervention 
group received 
screening questions and 
providers were alerted 
to positive screens and 
were provided with 
materials to share with 
mothers 
- in the control group 
providers were 
reminded to screen 
Sample: 
- intervention 
group receiving 
screening 
questions, n=1167 
 
- intervention 
group receiving 
screening 
questions and 
materials, n=1167 
 
-control group, 
n=1186 
 
Setting: 
- Academic 
pediatric clinic 
-CHICA 
Prescreening form 
with maternal 
depression 
questions  
 
- The Child Health 
Improvement 
through Computer 
Automation 
(CHICA) system is 
a decision support 
and electronic 
medical record 
system used in the 
study setting 
- x2 to test for 
differences 
between 
groups after 
randomization 
 
 
- Diagnosis of 
maternal depression 
and referral for 
assistance occurred 
significantly more 
often in both the 
screening (2.4%) 
and the screening 
and materials group 
(2.4%) than in the 
control group 
(1.2%) 
- OR 2.06 (95% CI 
1.08 to 3.93) 
Level II Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of 
Evidence 
Leung, S.L., 
Leung, C., Lam, 
T.H., Hung, 
S.F., Chan, R., 
Yeung, T., 
Miao, M, 
Cheng, S., 
Leung, S.H., 
Lau, A. & Lee, 
D.T. (2010). 
Outcome of a 
postnatal 
depression 
screening 
programme 
using the 
Edinburgh 
Postnatal 
Depression 
Scale: A 
randomized 
control trial. 
Journal of 
Public Health, 
33(2), 292-301. 
 
 
 
 
Design: 
- randomized control 
trial 
Method: 
- simple 
randomization 
generated by a 
research officer not 
involved in the rest of 
the study 
- participants in the 
intervention group 
were screened for 
PND using the EPDS 
- control group 
screened by clinical 
assessment 
 
Sample: 
- Mothers with 2 
month old babies, 
n=462 
 
Setting: 
- Maternal and 
child health 
centers in Hong 
Kong 
-Edinburgh 
Postnatal 
Depression Scale 
(EPDS) 
 
- The EPDS has 
been established as 
a valid and reliable 
screening tool for 
PND 
- SPSS 
version 14 
 
- Binary 
measure 
between 
intervention 
and control 
groups 
analyzed and 
presented as 
risk ration 
(RR) and 
95% 
confidence 
interval (CI) 
- The intervention 
group had better 
maternal mental 
health outcome at 
6 months postnatal 
(RR 0.59, 95% CI 
0.39-0.89) 
Level II Moderate 
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Citation Design/Method Sample/Setting Outcome 
Measurement 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of 
Evidence 
Yawn, B.P., 
Dietrich, A.J., 
Wollan, P., 
Bertram, S., 
Graham, D., 
Huff, J., 
Kurland, M., 
Madison, S. & 
Pace, W.D. 
(2012). 
TRIPPD: A 
practice-based 
network 
effectiveness 
study of 
postpartum 
depression and 
management. 
Annals of 
Family 
Medicine, 10(4), 
320-329.   
Design: 
- randomized control 
trial 
Method: 
- randomization was 
done by practice as the 
intervention involved 
changes in care at the 
practice level 
- intervention and 
usual care were not 
provided within the 
same practice 
 
Sample: 
- 28 practices 
randomized to 
usual care (n=14) 
or intervention 
(n-14) 
-2,343 women 
were enrolled 
between 5 and 12 
weeks’ 
postpartum 
- 1,897 (80.1%) 
provided 
outcome 
information and 
were included in 
the analysis 
 
Setting: 
- family medicine 
research network 
practices 
-Edinburgh 
Postnatal 
Depression Scale 
(EPDS) 
 
- 9-item Patient 
Health 
Questionnaire 
(PHQ-9) 
 
- A woman was 
classified as 
receiving the 
intervention if the 
clinic offered the 
intervention at the 
time of her 
enrollment 
 
- Primary outcome 
was a 5-point or 
greater drop in 
PHQ-9 score from 
baseline to 6 or 12 
months’ 
postpartum 
 
 
 
- S-PLUS 
statistics 
package 
(TIBCO 
Software, 
Inc.) 
 
- Generalized 
linear mixed 
effect models 
with a 
random mean 
term for the 
clinic 
 
- 654 (34.5% of 
1,897) women had 
elevated screening 
scores with 
comparable rates 
in the intervention 
and usual-care 
groups 
- Those in the 
intervention 
practices were 
more likely to 
receive a diagnosis 
(P=.0006) and 
therapy for 
postpartum 
depression 
(P=.002). This 
group also had 
lower depressive 
symptom levels at 
6 (P=.07) and 12 
months’ (P=.001) 
Level II Moderate 
 
 
3
2
 
 
Citation Design/Method Sample/Setting Outcome 
Measurement 
Data 
Analysis 
Findings Level of 
Evidence 
Quality of 
Evidence 
Chaudron, L.H., 
Szilagyi, P.G., 
Kitzman, H., 
Wadkins, H.I. & 
Conwell, Y. 
(2004). 
Detection of 
postpartum 
depressive 
symptoms by 
screening at 
well-child visits. 
Pediatrics, 
113(3), 551-558.    
Design: 
- cohort study 
 
Method: 
- implementation of 
universal screening for 
postpartum depressive 
symptoms during first 
year well-child visits 
using the Edinburgh 
Postnatal Depression 
Scale (EPDS). 
 
Sample: 
- n=110 
Cohort #1: 
randomly 
selected 110 
infant medical 
records before 
screening was 
initiated 
-n=110 
Cohort #2: 
randomly 
selected 110 
infant medical 
records after 
screening was 
initiated  
 
Setting: 
- large pediatric 
primary care 
practice affiliated 
with a medical 
center in a large 
city 
-Edinburgh 
Postnatal 
Depression Scale 
(EPDS) 
 
- The EPDS has 
been established as 
a valid and reliable 
screening tool for 
PND 
- x2 and 
Fisher’s 
exact test for 
detection and 
referrals 
- post hoc 
analyses 
using x2 and 
Fisher’s 
exact tests to 
compare 
detection at 
well-child 
visits in 
cohort 1 and 
well-child 
visits in 
cohort 2 
- 46% of visits in 
cohort 2 included 
an EPDS form in 
the medical record 
- among women 
who completed the 
EPDS, 27% (n=16) 
had high 
depressive 
symptoms at some 
time during the 
first year 
- statistically 
significant increase 
in detection from 
cohort #1 (1.6%) 
to cohort #2 
(8.5%) P<.001 and 
in referral (0.2%) 
to (3.6%) P<.005 
Level IV Moderate 
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attitudes and symptoms of depression and takes approximately 10 minutes to complete 
(American Psychological Association, 2015).  The BDI has been criticized as it primarily 
focuses on the somatic symptoms of depression which can often overlap with symptoms 
experienced during the postpartum period (Boyd, Le, & Somberg, 2005). 
 The Postpartum Depression Screening Scale (PDSS) is a 35-item tool that assesses 
seven dimensions: (a) sleeping and eating disturbances, (b) anxiety and insecurity, (c) 
emotional lability, (d) cognitive impairment, (e) loss of self, (f) guilt and shame, and (g) 
thoughts of self- harm. This tool takes five to 10 minutes to complete (Beck & Gable, 2000).  
The Edinburgh Postnatal Depression Scale (EPDS) is the tool most commonly used to assess 
for depression in the postpartum period.  This 10-item questionnaire, takes less than 5 
minutes to complete and assesses the emotional and cognitive symptoms of PPD with one 
question to measure sleep disturbances (Boyd, Le, & Somberg, 2005).  The EPDS has been 
the most researched tool used to measure PPD.  Table 6 provides a comparison of screening 
tools considered for this project. 
Implications for Practice 
 The synthesis of evidence from this review indicated that there is a need for early 
identification of PPD as it has serious negative effects on maternal well-being and infant 
development (Liberto, 2012).  The quality and grade of the evidence also indicated that there 
are valid screening tools for PPD, screening is acceptable to mothers and pediatric providers 
and screening at well-child visits can successfully identify mothers at risk for PPD 
(Chaudron, Szilyagyi, Kitzman, Wadkins and Cornwell, 2004).  A synthesis table outlining 
the important elements included in this review is provided in Table 7. 
Recommendation for Practice Change 
 Based on the level, quality and strength of the evidence, the recommendation was to 
screen postpartum mothers for PPD using the EPDS at well-child visits during the first year  
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Table 6 
 
Postpartum depression screening tools comparison 
Tool Length 
of use 
Time period 
for assessment 
Developed 
for use in 
postpartum 
women 
Cost for 
use 
Sensitivity and 
specificity 
Patient Health 
Questionnaire-9 
(PHQ-9) 
9 items Adults at any 
time 
No Free 88% sensitivity 
88% specificity 
 
 
Patient Health 
Questionnaire-2 
(PHQ-2) 
2 items Adults at any 
time 
No Free 83% sensitivity 
92% specificity 
 
 
Beck Depression 
Inventory (BDI) 
21 items Adults at any 
time 
No $105 
(manual and 
50 forms) 
47.6-82% 
sensitivity 
85.9-89% 
specificity 
 
Postpartum 
Depression 
Screening Scale 
(PDSS) 
35 items Postpartum Yes $79.75 
(manual and 
25 forms) 
91-94% 
sensitivity 
72-98% 
specificity 
 
Edinburgh 
Postnatal 
Depression 
Screening Scale 
(EPDS) 
10 items Prenatal and 
postpartum 
Yes Free 59-100% 
sensitivity 
49-100% 
specificity 
(American Psychological Association, 2015; Beck & Gable, 2000; Boyd, Le, & Somberg, 
2005; Kroenke, Spitzer & Willliams, 2001; National Institute for Healthcare Management, 
2010) 
 
of life and to provide resources and referrals as indicated.  
 The EPDS is the most commonly used and validated tool used to screen for PPD and 
was chosen to use for this project (Appendix A).  The EPDS is free to use for screening 
purposes as long as it is used in its entirety and copyright laws are followed by always 
including the names of the authors and the title of the article and journal in which it first 
appeared (Cox, Holden & Sagovsky, 1987).  The screening tool contains 10 questions 
including one on suicidal ideation and is completed by the patient and is easily and quickly 
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Notes: Edinburgh Postnatal Depression Scale (EPDS), Beck Depression Inventory (BDI), Patient Health Questionnaire-2 (PHQ-2), The Child Health 
Improvement through Computer Automation (CHICA), +-positive for PPD, ≠-not applicable, Δ-responsible for screening, ¢-not responsible for screening, ¥-
acceptability of screening, ©-effectiveness of screening 
Table 7 
 
Synthesis Table 
Study 
Author 
Year Persistence 
of PPD 
Pediatric 
Providers’ 
Beliefs 
Acceptability 
of Screening 
Effectiveness 
of Screening 
Screening 
Tool Used 
Sample Size Level of 
Evidence 
Quality of 
Evidence 
Chaudron et 
al 
2006 + ≠ ≠ ≠ EPDS 67 VI Moderate 
Liberto 2012 + ≠ ≠ ≠ ≠ 311 V Moderate 
Stowe and 
Hostetter 
2005 + ≠ ≠ ≠ EPDS and 
BDI 
209 VI Moderate 
Olson et al 2002 ≠ Δ ≠ ≠ ≠ 508 VI Moderate 
Leiferman et 
al 
2008 ≠ Δ ≠ ≠ ≠ 17 VI Low 
Heneghan et 
al 
2007 ≠ Δ ≠ ≠ ≠ 23 VI Moderate 
Goldsmith 2007 ≠ Δ ≠ ≠ ≠ 159 VI Moderate 
Mason and 
Poole 
2008 ≠ Δ ≠ ≠ EPDS 19 VI Moderate 
Santos et al 2013 ≠ ¢ ≠ ≠ ≠ 17 VI Moderate 
Brealey et al 2010 ≠ ≠ ¥ ≠ EPDS and 
BDI 
16 V Low 
Gjerdingen 
et al 
2009 ≠ ≠ ¥ ≠ PHQ-2 506 VI Low 
Olson et al  2006 ≠ ≠ ¥ ≠ PHQ-2 1,398 IV Moderate 
Walker et al 2013 ≠ ≠ ¥ ≠ ≠ 145 VI Moderate 
Byatt et al 2013 ≠ ≠ ¥ ≠ ≠ 27 VI High 
Carroll et al 2013 ≠ ≠ ≠ © CHICA 1167 II Moderate 
Leung et al 2010 ≠ ≠ ≠ © EPDS 462 II Moderate 
Chaudron et 
al 
2004 ≠ ≠ ≠ ©  110 IV Moderate 
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scored by office staff and reviewed by providers.  The EPDS has a maximum score of 
30 with a score of 10 or greater indicating possible depression.  Question 10, which 
assesses suicidal thoughts, should always be reviewed separately (Hirst & Moutier, 
2010). 
 The recommendation for a practice change and the strength and rationale for 
the recommendation are shown in Table 8.
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Table 8 
 
Recommendation for Practice Change 
Recommendation Strength of Evidence for 
Recommendation 
Rationale References in Support of 
Recommendation 
1. Implement a program to screen 
postpartum mothers for 
Postpartum Depression (PPD) in 
pediatric clinics using the EPDS 
Strong Demonstrates increase in 
identification of Postpartum 
Depression (PPD) in the pediatric 
setting with formal screening 
 
Identified persistence of PPD 
throughout the 12 months after 
delivery 
 
Carroll, A.E., et al. (2013); 
Chaudron, L.H., et al. (2004); 
Stowe, Z., et al. (2005); 
Chaudron, L.H., et al. (2006) 
 
2. Implement PPD screenings at 
the 2 week, 2 month, 4 month, 6 
month, 9 month, and 12 month 
visit 
Strong Universal screening for PPD at well-
child visits during the first year of life 
showed statistically significant 
increase in detecting PPD 
 
Mothers more likely to complete PPD 
screening at pediatric clinics than at 
family medicine clinics 
 
Women’s interaction with their 
provider ends shortly after birth and 
there is frequent interaction with 
pediatric providers throughout a 
child’s first year of life 
Chaudron, L.H., et al. (2004); 
Gjerdingen, D., et  
al. (2009); 
Liberto, T.L. (2012) 
Siu, A.L. (2016) 
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Recommendation Strength of Evidence for 
Recommendation 
Rationale References in Support of 
Recommendation 
3. Provide training on 
implementation of the screenings 
to clinic staff 
Strong Training in the use of a screening tool 
increased identification of PPD 
 
Screening for PPD during well-child 
visits did not take significantly more 
time 
 
Pediatric providers believe it is their 
responsibility to recognize PPD but 
cite lack of training 
 
Pediatric providers cited lack of 
confidence in how to use a screening 
tool was the greatest barrier to 
screening 
 
Yawn, B.P., et al. (2012); 
Olson, A.L., et al. (2006); 
Olson, A.L., et al. (2002); 
Leifernean, J.A., et al. (2008); 
Heneghan, A.M. et al. (2007); 
Mason, L., et al. (2008); 
Goldsmith, M.E. (2007); 
Santos, H.P., et al. (2013) 
4. Discuss screening results with 
mothers and provide referrals to 
community resources 
Strong Mothers screened for PPD at well-
child visits had improved mental 
health outcomes at 6 months 
postpartum 
 
Demonstrated that screening for PPD 
at well-child visits is acceptable to 
women and healthcare providers 
Mothers found it acceptable to 
discuss maternal health needs at 
pediatric visits 
Leung, S.L., et al. (2010); 
Brealey, S.D., et al. (2010); 
Olson, A.L., et al. (2006); 
Walker, L.L., et al. (2013); 
Byatt, N., et al. (2013) 
Siu, A.L. (2016) 
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 III. IMPLEMENTATION 
Setting and Population 
 The setting for this project was a private pediatric practice in the Midwest that 
is located in a small town in a rural community.  The practice sees children from birth 
to age 18 with a total patient population of approximately 14,000.  There are eight 
providers including three physicians and five pediatric nurse practitioners.  Support 
staff includes seven licensed practical nurses, two receptionists, a billing manager and 
an office manager.   
 The population of interest included neonates, infants and mothers who 
presented for well-child visits at the following scheduled intervals: two weeks, two 
months, four months, six months, nine months, and 12 months of age.  In 2015, the 
pediatric practice for the project saw 1,660 infants, age two weeks to one year, for 
well-child visits. Therefore, this would result in an average of 415 potential subjects 
over the three-month proposed project period.  Stakeholders identified for this project 
were postpartum mothers and their neonates and infants, pediatric providers, clinic, 
administration and payers.  
Evidence-Based Practice Improvement Project Approval 
 The project was designed to not place the participants at risk with privacy 
concerns addressed by de-identification of all protected health information (PHI) 
aimed at upholding HIPAA compliance.  Agency permission to complete the EBPI 
project was obtained from the private pediatric clinic (Appendix B).  The project 
proposal was submitted to Dayton Children’s Institutional Review Board and was 
determined to qualify as a non- research, quality improvement project with permission
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to proceed granted (Appendix C). 
 Aim Statement 
 Within three months of initiation of the project, providers will screen mothers 
for PPD, using the EPDS, during their infant’s well-child visit greater than or equal to 
80 percent of the time.  Mothers who present with their children for well-child visits 
will be identified and the number who receive screening and receive information and 
referral will be measured.  The total number of mothers eligible for screening will be 
compared to the actual number of mothers who receive screening.  This is a process 
measurement and will demonstrate if the appropriate steps to benefit patients are 
performing as planned (National Quality Forum, 2016).  The aim to achieve an 80% 
rate of screening was determined through conversations between the DNP student and 
the office manager and providers.  Since screening for PPD was not currently 
practiced, an 80% screening rate over three months seemed to be a reasonable and 
attainable goal for initial implementation. 
Implementation Plan 
 Several employees at the clinic, along with the DNP student, were involved in 
the implementation of the project.  The team was responsible for providing education 
on use of the screening tool, developing documentation within the electronic medical 
record (EMR), completing screening, and providing resources and referrals when 
indicated. The team members are listed in Table 9.    
 The DNP student served as the project leader and developed an educational 
module for providers and staff regarding the project, submitted the IRB application, 
served as a resource during implementation of the project, and completed data 
collection and analysis.  The office manager of the clinic arranged time for providers 
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and staff to participate in the educational training and worked closely with the DNP 
Table 9 
 Project Implementation Team 
Role Duties Agency 
 
DNP Student/Project 
Leader 
 
Design and implement 
project 
Provide education to staff 
Wright State University 
Office Manager Assist with data collection Child and Adolescent 
Specialty Care 
Pediatric Nurse 
Practitioner 
Create documentation of 
screening within the EMR 
Implement screening 
Child and Adolescent 
Specialty Care 
Pediatric Nurse 
Practitioners 
Implement screening Child and Adolescent 
Specialty Care 
Pediatricians Implement screening Child and Adolescent 
Specialty Care 
Charge Nurse Provide leadership to staff 
nurses and receptionists in 
distributing screening tool 
at appropriate visits 
Child and Adolescent 
Specialty Care 
Statistician Data analysis Wright State University 
 
student to ensure a smooth implementation of the project.  A pediatric nurse 
practitioner with specialized training on the EMR developed documentation of the 
screening within the appropriate patient encounter templates.  Another pediatric nurse 
practitioner worked closely with the DNP student and provided information about 
issues regarding project implementation while the DNP student was not available in 
the office.  The charge nurse maintained close communication with staff nurses and 
receptionists and assisted in identifying appropriate visits for screening and assuring 
that screening tools were provided to eligible mothers.  In addition, a statistician 
provided statistical support to the DNP student after data collection was completed 
and the project was concluded. 
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Staff Education. Prior to implementation of the project, staff and providers 
received education on the principles of EBP, the prevalence and risks of PPD for 
mothers and children, and training on the use of the EPDS to screen for depression.  
Education included a PowerPoint presentation (Appendix D) as the addition of a 
visual component has been shown to increase the retention of information by 24% 
(Simmons & DiStasi, 2008).  Training on use of the EPDS occurred in groups of four 
or less and included education about the tool, instructions on tool completion and 
scoring, and practice completing and scoring the tool.  The inclusion of the active 
learning techniques of hearing the information, seeing the information, and interacting 
with the actual tool was utilized as combining these techniques leads to information 
retention rates as high as 97% (Simmons & DiStasi, 2008).  Appendix (E) shows the 
teaching plan for staff and provider education.  
 Screening Process.  The steps for the screening process were as follows: 
 1.  The mother was provided with an information letter (Appendix F) and the 
EPDS when she and her infant were brought to the exam room by the licensed 
practical nurse (LPN).  After the third PDSA cycle, mothers were provided this 
information at check-in.  
 2.  While waiting for the provider, the mother completed the EPDS and placed 
the completed scale on the exam table.  If the mother did not complete the EPDS there 
were no further prompts to participate in the screening process.  However, general 
questions regarding the mother’s well-being were asked as this was the usual practice 
of the providers in the office. 
 3.  During the well-child visit the provider scored the EPDS.  The completion 
of the EPDS and score were recorded in the EMR. 
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 4.  The provider discussed the EPDS score with the mother.  If the EPDS score 
was less than 10 there was no further intervention.  If the EPDS score was 10 or 
greater, the mother was referred to her primary care provider for further evaluation 
and treatment. The mother was provided a brochure from Postpartum Support 
International (Appendix G) and Many Shades of Blue (Appendix H).  If question 
number 10 of the EPDS was positive, the mother and infant were not left alone and 
emergency services were contacted if indicated.  Documentation for each of these 
encounters was made in the EMR.  Providers were given a decision-making algorithm 
(Appendix I) which outlined the steps to take based on the EPDS score.  Algorithms 
were posted in each provider’s office and on the bulletin board in the hallway for ease 
of use. 
 Melnyk and Fineout-Overholt (2015) assert that for a change to evidence-
based practice to happen a strategic plan with clearly established goals must be 
developed.  Table 10 outlines the timeline for implementation of the project. 
Outcome Measures 
Screening for PPD was not conducted in the pediatric practice before the 
implementation of this project.  An area to record a completed screening was added to 
the EMR.  The number of completed screenings was measured by a review of the 
EMR after implementation of the project.  For this project, the number of mothers 
who brought their infant in for a well-child visit and the number of mothers who were 
actually screened for PPD using the EPDS was measured.  In addition, another area 
was added to the EMR for the provider to record the distribution of resource packets 
and referrals given to mothers.  
Increasing PPD screening assisted in identifying mothers with this condition 
who were then provided resources and referred to their primary care provider for 
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Table 10 
 
EBP Project Implementation Timeline 
 
Step 1: Describe the Problem 
• Mothers not screened for PPD during the first year of 
infant’s life 
• Identify key stakeholders 
• Identify facilitators and barriers and develop strategies 
for addressing 
 
January 2014 
 
September 2016 
September 2016 
Step 2: Formulate Focused Clinical Question 
• Development of PICOT question 
 
February 2014 
Step 3: Search for Evidence 
• Identify keywords identified in PICOT question 
• Conduct literature search 
 
February 2014 
Step 4: Appraise and Synthesize Evidence 
• Utilize Rapid Critical Appraisal method 
• Identify level of evidence 
• Grade evidence 
• Evaluate and select appropriate screening tool for PPD 
 
March 2014 
March 2014 
September 2015 
November 2015 
Step 5: Develop Aim (goal) Statement 
• Develop Aim Statement for project  
• Defend proposal 
• IRB application 
 
October 2016 
October 2016 
January 2017 
Step 6: Plan-Do-Study-Act cycles 
• Develop and present education module for screening for 
PPD 
• Implement small tests of change 
• Implement project with changes identified after rapid 
PDSA cycles 
• Data analysis 
 
February 2017 
 
March-May 2017 
 
Step 7: Dissemination of Best Practices 
• Final defense of project 
 
 
November 2017 
 
further evaluation and treatment.  Resources included a brochure from Postpartum 
Support International (2016) which provides information about the symptoms of PPD, 
self-care tips, and phone and website information for support groups (Appendix G) 
which was reproduced and distributed free of charge.  A brochure from a local PPD 
support group was also provided to mothers with positive screens and was provided 
by the organization free of charge (Appendix H). For mothers who screened positive 
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for PPD, providing information, resources, and referral to their primary care provider 
may improve the health outcomes of mothers, infants, and families. 
In addition, early identification and treatment of PPD has the potential to 
reduce health care costs.  Depression, especially when identified early, is highly 
treatable.  Early interventions have the potential to reduce negative outcomes for both 
mother and infant, thus reducing the significant financial burden of depression 
(National Institute of Health Care Management, 2010).   
Facilitators and Barriers 
 Considering facilitators and barriers is a necessary step when considering any  
change.  As Melnyk and Fineout-Overholt (2015) assert, “change, even when 
welcome, is stressful to everyone” (p. 206).   
 The office manager of the practice was a primary facilitator during the 
development and implementation of the project.  The project leader maintained this 
support through frequent conversations with the office manager in person, by phone, 
and through email.  Through these discussions, the project leader provided evidence 
of the value of the project to the practice and its patients, worked to develop an 
explicit timeline of the project activities, acquired resources to be provided to 
mothers, and assured the manager that the time to complete the project would not 
interfere with contracted clinical hours.   
 Two pediatricians and two nurse practitioners also served as facilitators for the 
project.  One pediatrician, a co-owner of the practice, was committed to implementing 
new evidence-based practices.  The other pediatrician, who recently completed 
residency training, was familiar with PPD screening and was encouraging to others in 
the practice regarding the importance of screening mothers for PPD.  One of the nurse 
practitioners had acquired additional training on the EMR and was helpful in 
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developing the documentation of the screening in the EMR.  The other nurse 
practitioner works full-time and was enthusiastic and supportive of the project from 
its inception.  She provided frequent feedback throughout the project and served as a 
resource when the project leader was not at the office. 
 Unfamiliarity with the principles of EBP and lack of knowledge regarding the 
EPDS screening tool were anticipated barriers to the project.  Another anticipated 
barrier was concern over the time needed to complete and score the screen.  These 
concerns were addressed during the education sessions included in the initial PDSA 
cycle.   
 An unanticipated barrier was reluctance to implement the project by a 
pediatrician and nurse practitioner.  These providers were included in many 
discussions regarding the development of the project and only verbalized their 
hesitancy for implementation during the initial PDSA cycle.  Individual conversations 
were held with the providers, the office manager, and the project leader to address 
their concerns.  The pediatrician eventually agreed to implementation while the nurse 
practitioner refused to implement the screening.  The nurse practitioner subsequently 
went on maternity leave during week 10 of the project and remained out of the office 
for the remainder of the project.  
 In Table 11, facilitators and barriers for the DNP project are identified as well 
as the methods utilized to address these during project implementation.   
Implementation Process 
Small tests of change occur during step six of the EBPI model, known as the 
plan-do-study-act cycle (PDSA), (Leven, et al., 2010).  To facilitate this process, 
forms provided by the Institute for Healthcare Improvement (IHI) for testing change 
were utilized for periodic evaluations throughout the project (Appendix J). 
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Table 11 
 
Facilitators and Barriers  
Facilitators How Addressed in Implementation 
 
• Practice manager supportive of 
providers  
• Provided evidence of value of the 
project to the practice; provided 
timeline of project; acquire 
resources; DNP student/employee 
provided time to practice outside of 
obligated hours to implement project 
• Pediatricians • Solicited advice and expertise; 
included in all phases of project 
• Pediatric Nurse Practitioners • Verbalized appreciation for 
assistance in creating documentation 
within the EMR and for serving as a 
resource during the project leader’s 
absence 
Barriers How Addressed in Implementation 
 
• Unfamiliarity with EBP principles • Developed and provided presentation 
to providers and staff about EBP and 
benefits to patient population 
• Knowledge deficit regarding use of 
screening tool 
• Provided education and practice in 
use of screening tool 
• Additional time for screening 
 
 
 
• Providers reluctance to implement 
screening 
 
• Implementation of screening during 
patient check-in and review by 
provider will not add significant time 
to well-child visit 
• Individual conversations with project 
leader and officer manager to address 
concerns 
 
During the 14-week project, nine PDSA cycles were completed.  Each cycle 
included an aim to guide the process.  The first step or “Plan” included describing 
what was the first or next test of change, listing the steps necessary to complete this 
test, predicting what would happen during the test, and what measures would be used 
to determine success.  The “Do” step included implementing the test and describing 
exactly what happened during the cycle.  During the “Study” step the results of the 
test were measured and compared to the predictions in order to learn from each cycle.  
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Finally, the “Act” step included evaluating what was learned and planning 
modifications to the plan for the next cycle (IHI, 2016).  See Appendix K for the 
individual 9 PDSA cycles.  
Although the project leader had discussed the project with all providers and 
staff throughout development, the first cycle was a formal introduction of the project 
over a one-week period.  The educational session was conducted, as described 
previously.  After the presentation and practice administering and scoring the EPDS 
in small groups occurred, an opportunity was provided for discussion.  All providers 
and staff demonstrated how to administer and score the EPDS during practice 
sessions.  Providers and staff verbalized the concern that administering the EPDS at 
the 9-month and 12-month well-child visits would be impractical as a time-intensive 
infant developmental screen was already administered at these visits.  All but two 
providers, a pediatrician and pediatric nurse practitioner, expressed enthusiasm about 
implementation of the project.  Specifically, they were concerned that since the 
mother was not a patient of the practice this would place them at legal risk if the 
mother screened positive for being at-risk for depression.  After receiving this 
feedback, it was decided to implement PPD screening at the 2 week, 2 month, 4 
month, and 6 month well-child visits.  Although this was a change from the initial 
project plan, it was consistent with a recommendation from the Ohio chapter of the 
AAP which recommended screening for PPD at the 2 week, 2 month, 4 month, and 6 
month well-child visits (American Academy of Pediatrics, Ohio Chapter, 2017).  To 
address the concerns expressed by the two providers, additional meetings were held 
with the project leader, office manager, and providers to review the evidence and 
recommendations supporting the project. 
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During PDSA cycle 2, implementation of PPD screening with two providers 
was initiated over a one-week period.  In addition, the project leader and a pediatric 
nurse practitioner with EMR expertise, created documentation for PPD screening 
within the EMR.  The documentation included whether documentation of the 
screening, the EPDS score, and if resources and referral were completed as indicated.  
Before the providers began screening the screening procedure, available resources and 
appropriate documentation were reviewed with the providers.  During this cycle two 
mothers were identified as eligible to screen and both screens were completed.  
Documentation in the EMR was completed for all screens.  The results were reviewed 
with the office and manager and providers and the providers verbalized confidence in 
scoring and reviewing the EPDS results with mothers in a timely manner.  It was 
decided that implementation of the project would continue for the next two weeks and 
an additional provider would begin screening. 
Before the third PDSA cycle began the screening procedure, resources, and 
appropriate documentation in the EMR was reviewed with the additional provider.  
During this test, 10 mothers were eligible for screening and two screens were 
completed.  All screens were documented in the EMR.  The results were reviewed 
with the office manager and providers.  The providers felt that since mothers were 
provided the EPDS by the LPN as they came to the exam room that there was not 
adequate time for the screen to be completed before they began their visit.  After 
discussing possible solutions, it was determined that the EPDS would be given to the 
mother at check-in by the receptionists to allow further time for completion.  The 
implementation would continue with this new procedure and the addition of another 
provider for the next week.   
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During the fourth PDSA cycle an additional provider began screening which 
brought the total to four providers.  Again, the screening procedure, available 
resources and documentation in the EMR was reviewed with this provider.  In 
addition, the change to provide mothers with the EPDS at check-in was discussed 
with the staff.  During this one-week cycle, 10 mothers were eligible for screening 
and nine completed a screen.  Documentation was completed for seven of the screens 
in the EMR.  While reviewing the results with the providers and office staff everyone 
felt that providing the EPDS at check-in increased the likelihood of the screen being 
completed and allowed the providers to score and review the screen with mothers in a 
timely manner.  It was determined that two more providers would begin screening 
during the next test of change and that the EPDS would continue to begin to the 
mother at check-in. 
Before beginning the fifth PDSA cycle the screening procedure, available 
resources, and appropriate documentation in the EMR was reviewed with the 
additional providers.  This test occurred over a two-week period with 34 mothers 
eligible for screening and 21 screens completed.  Documentation of screening in the 
EMR was completed for 18 screens.  The results from this test were reviewed with the 
office manager and providers with providers stating that some mothers were not 
completing the screens and per the project protocol they were not prompting the 
mothers further.  The providers also stated that they were receiving positive feedback 
about the screening from mothers who completed the EPDS and all of the providers 
expressed confidence in scoring and reviewing the EPDS with mothers. 
Implementation of the project was scheduled to continue for another cycle with the 
addition of two providers.   
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During the sixth PDSA cycle, with the addition of two more providers, all 
providers in the office were scheduled to be screening for PPD at eligible visits.  
During this two-week test, 52 mothers were eligible for screening and 33 screens were 
completed.  All screens were documented in the EMR.  After the results were 
reviewed with the office manager and providers it was revealed that one of the 
providers, a pediatric nurse practitioner, had communicated to the staff not to provide 
eligible mothers with the EPDS as she was not comfortable with screening and would 
be beginning maternity leave within the next few weeks.  All other providers 
continued to express confidence in scoring and reviewing the EPDS with mothers and 
stated that they were receiving positive feedback from mothers who were screened.  
The office manager met privately with the provider who refused to screen and 
communicated that all providers were expected to provide screening at this time.  The 
next cycle was scheduled to continue implementation of the project with all providers.   
The seventh PDSA cycle was completed over two weeks with all providers 
involved at this time, except for the provider who had refused to screen and had 
subsequently started maternity leave.  Thirty-seven mothers were eligible to screen, 
30 screens were completed, and all screens were documented in the EMR.  During the 
review of the cycle providers continued to express confidence in scoring and 
reviewing the EPDS with mothers and also continued to receive positive feedback 
from mothers.  Implementation of the project, without changes, was set to continue in 
the next cycle. 
For the eighth PDSA cycle all providers continued to screen.  There were 61 
mothers eligible to screen and 42 screens were completed.  Documentation in the 
EMR was completed for all screens.  While reviewing results of the cycle the office 
manager reported that she had received feedback from an obstetrician’s office.  The 
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office reported that one of their patients was screened for PPD at a well-child visit and 
returned to their office for evaluation and treatment.  They expressed gratitude that the 
office was offering PPD screening to mothers.  Everyone expressed satisfaction with 
this feedback and with the screening process as it had been implemented.  For the next 
cycle, all providers would continue screening.   
The ninth PDSA cycle was the final cycle and all providers were screening at 
this time.  Although project outcomes and plans for sustainability had been discussed 
informally throughout the project, the office manager made arrangements for an office 
meeting with providers and staff to review these items as well as the results from the 
final test.  During this cycle, there 49 mothers eligible to screen and 21 screens 
completed.  All screens were documented in the EMR.  During review of the 
screening numbers for this test it was discovered that the two regular receptionists had 
each been on vacation on alternate weeks.  The person who substituted for them was 
not familiar with the process of providing mothers with the EPDS at check-in and it 
was felt that this led to the decrease in completed screens.  
Preliminary project outcomes were also reviewed at this time and there was 
unanimous agreement among the providers and staff that screening for PPD had been 
a positive experience and that the practice would continue to offer screening.  The 
office manager had already spoken with the provider who had previously refused to 
screen and established clear expectations for screening when she returned from 
maternity leave.  As the documentation was already in the EMR and resources were 
available the project was stable and could continue without changes.  The project 
leader expressed appreciation for the cooperation of the providers, office manager, 
and staff during the project and congratulated them for their hard work and successes.  
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Plans were made for a future meeting where the project leader would share outcomes 
from the project after review and data analysis.   
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IV. PROJECT EVALUATION 
 During implementation of this evidence based practice improvement project, 
data were collected during the multiple PDSA cycles as recommended by Levin et al. 
(2010).  This was an essential step in order to adequately evaluate the outcomes for 
this project.  Outcome measures for this three-month project included the number of 
mothers eligible to screen for PPD, the number of mothers who completed a screen 
for PPD, and documentation in the EMR.  Demographic data was also collected and 
included the mother’s age, mother’s race, marital status, the infant’s age, the infant’s 
gestational age, the type of infant feeding, and the type of insurance.   
Data Collection 
Data collection was accomplished by retrospective chart review.  Informed 
consent was not required for this proposed project; however, an information letter was 
provided to every eligible participant (Appendix F).  Data was collected by the DNP 
student, biweekly during project implementation and at the conclusion of the project. 
Data was entered into the data collection tool (Appendix L) and subsequently entered 
into a password protected Excel spreadsheet. At no time were any protected health 
information identifiers, which linked the infant or mother’s information, entered on 
either the data collection sheet or the Excel spread sheet.  A flash drive was used for 
routine storage and transportation of data.  When the drive was not in use, it was 
stored in a locked file cabinet in the DNP student’s home office.   
Data Analysis 
 At the conclusion of the project, all de-identified data was placed in an Excel 
spreadsheet.  The statistician was consulted for data analysis to ascertain statistical
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and clinical significance.  Analysis of descriptive statistics was conducted on the 
available data.  
 Although there was insufficient data to perform logistic regression on the 
dependent variable (screening result) and the seven independent variables (mother’s 
age, mother’s race, marital status, age of infant, gestational age of infant, infant 
feeding, and type of insurance) at one time, logistic regression was conducted with 
each individual variable.  
Results 
 Demographics.  During the 14-week project, 160 mothers completed the 
EPDS.  The age of mothers ranged from 17 to 40 years, with a mean age of 28 years 
(SD = 5.08).  Logistic regression analysis showed that the mother’s age was a 
significant predictor of PPD (p = .035, df= 1).  The coefficient was negative which 
indicated that as age increased the likelihood of being at risk for postpartum 
depression decreased, OR = .907, 95% CI [.828-.993], p = .035.   Therefore, for every 
one year of increase in maternal age, the odds of screening positive for PPD decreased 
by 9.3%.  Figure 1 shows the age of mothers screened during the project. 
 The race of the majority of subjects in the project was white (94.4%, n = 151).  
Since there were few minorities, subjects were coded as either “white” or “not white” 
and a logistic regression was analyzed for the variables of race and postpartum 
depression.  Race was a significant predictor of postpartum depression, OR = 4.691, 
95% CI [.053-.856], p = .029.  However, the effect size was very small (R2 = .026) 
and by no means implies that non-white subjects have the same experiences with 
PPD.  Table 12 describes the frequency of maternal race of project subjects.  
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Table 12 
Mother’s Race 
Race Frequency Percent Cumulative Percent 
African-American 8 5.0 5.0 
Asian 1 .6 5.6 
Caucasian 151 94.4 100 
Total 160 100.0  
 
 A majority (59%, n = 95) of mothers who completed the EPDS were married.  
Logistic regression analysis showed that marital status was not a significant predictor 
of PPD (p =.07).  Marital status is depicted in Table 13. 
Table 13 
Marital Status 
Marital Status Frequency Percent Cumulative Percent 
Divorced 3 1.9 1.9 
Married 95 59.4 61.3 
Single 62 38.8 100.0 
Total 160 100.0  
 
 The age of infants brought by mothers for well-child visits ranged from 2 
weeks to 24 weeks.  The mean age of infants was 10.8 weeks (SD = 7.74).  Logistic 
 
 
 
 
 
 
 
 
 
Figure 1: Age of mother 
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regression analysis showed that the age of the infant was not a significant predictor of 
maternal PPD (p = .46).  The frequency of age of infants in weeks is depicted in 
Figure 2.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
The gestational age of the infant at birth was also collected.  Gestational age 
ranged from 31 weeks to 41 weeks with a mean of 38.7 weeks (SD = 1.31) indicating 
the majority of participant’s infants were term at birth.  Logistic regression analysis 
indicated that the gestational age of the infants was a significant predictor of PPD in 
mothers (p = .050, df = 1).  The coefficient was negative which indicated that as the 
gestational age of the infant increased the likelihood of being at risk for postpartum 
depression decreased, OR = .747, 95% CI [.558-1.000], p = .050.  Therefore, for 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Infant’s age. 
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every week of increase in gestational age, the odds of the mother screening positive 
for PPD decreased by 25.3%.  Figure 3 depicts the gestational age of infants. 
 
 
  
 
 
 
 
 
 
 
 
 
 
The type of feeding method (breastfed or bottle fed) that infants received was 
collected.  A majority (60%, n = 97) of infants were breastfed.  Logistic regression 
analysis showed that the type of feeding was not a significant predictor of maternal 
PPD (p = 0.23).  Type of infant feeding is shown in Table 14.  
Table 14 
Type of Infant Feeding 
Type of Feeding Frequency Percent Cumulative Percent 
Breastmilk 97 60.6 60.6 
Formula 63 39.4 100.0 
Total 160 100.0  
 
 The type of insurance for the infant was collected with a majority (63%, n = 
101) of infants being covered by private insurance.  Logistic regression analysis 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Gestational age of infant. 
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showed that the type of insurance was a significant predictor of PPD in mothers (p = 
.043, df = 1).  The coefficient was negative which indicated that having insurance 
through Medicaid increased the likelihood of being at risk for postpartum depression 
decreased, OR = .414, 95% CI [.117-.971], p = .043.  Therefore, subjects who did not 
have Medicaid, but private insurance would decrease the odds of screening positive 
for PPD by 58.6%.  Table 15 depicts the type of insurance. 
Table 15 
Type of Insurance 
Insurance Frequency Percent Cumulative Percent 
Medicaid 57 35.6 35.6 
Private 101 63.1 98.8 
Self-pay 2 1.3 100.0 
Total 160 100.0  
 
EPDS Scores 
 Total Score.  The EPDS instrument total score could range from zero (no 
signs of depression) to 30 (extreme signs of depression).  EPDS scores ranged from 
zero to 21 with a mean score of 5.29 (SD = 4.37).  Scores collected during the project 
are shown in Figure 4. 
Screen Results.  The score obtained from the EPDS indicates whether or not a 
mother is at risk for PPD.  During this project, approximately 16% (n = 26) of 
mothers were identified to be at risk for PPD.  Table 16 depicts EPDS screen results. 
Table 16 
EPDS Screen Results 
EPDS Results Frequency Percent Cumulative Percent 
Negative for PPD risk 134 83.8 83.8 
Positive for PPD risk 26 16.3 100.0 
Total 160 100.0  
 
Potential for Self-Harm.  Question 10 of the EPDS assess suicidal thoughts 
and was reviewed separately.  Of the 160 mothers screened, there were three (1.9%) 
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positive responses.  The responses to question 10 are shown in Table 17.  
Table 17 
Response to Question 10 
Response to Question 10 Frequency Percent Cumulative Percent 
Yes 3 1.9 1.9 
No 157 98.1 100.0 
Total 160 100.0  
 
EPDS Screening Results  
 During the 14-week project, 255 mothers were identified as eligible for PPD 
screening and 160 mothers completed the screen (62.74%). The frequency of 
screening, by week, is depicted in Table 18.  
A run chart is an important tool in quality improvement as it displays changes 
in data over time.  This is especially useful in showing how well a process is, or is 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: EPDS scores 
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Table 18 
Frequency of PPD Screening by Week 
Week Eligible to Screen Completed Screen Percent Screened 
Week 1 2 2 100.0% 
Week 2 7 1 14.3% 
Week 3 3 1 33.3% 
Week 4 10 9 90.0% 
Week 5 15 8 53.3% 
Week 6 19 13 68.4% 
Week 7 20 17 85.0% 
Week 8 32 16 50.0% 
Week 9 10 10 100.0% 
Week 10 27 20 74.1% 
Week 11 24 18 75.0% 
Week 12 37 24 64.9% 
Week 13 20 11 55.0% 
Week 14 29 10 34.5% 
    
Total  255 160 62.7% 
 
not, performing and what changes or adaptions may be needed for further 
improvement (Institute for Healthcare Improvement [IHI], 2017).  Figure 5 shows the 
percentage of mothers screened for PPD, by week, during implementation of the 
project.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Percent of mothers screened for PPD within 3 months 
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EMR Documentation 
           Documentation in the EMR of the results of screening and providing resources 
and referrals, as indicated, was also collected.  Table 19 shows results on a weekly 
basis.   
Table 19 
Documentation in the EMR 
Week Screen Documented Percent Documented 
Week 1 2 2 100% 
Week 2 1 1 100% 
Week 3 1 1 100% 
Week 4 9 6 67% 
Week 5 8 5 63% 
Week 6 13 13 100% 
Week 7 17 17 100% 
Week 8 16 16 100% 
Week 9 10 10 100% 
Week 10 20 20 100% 
Week 11 18 18 100% 
Week 12 24 24 100% 
Week 13 11 11 100% 
Week 14 10 10 100% 
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V. DISCUSSION 
Findings from Project Implementation 
 The purpose of this evidence-based practice improvement project was to 
implement PPD screening for mothers who bring their infants for well-child visits, 
during the first year of life, at a private pediatric practice.  The aim was that within 
three months of project implementation providers would screen for PPD, using the 
EPDS, at greater than or equal to 80 percent of the time.  The outcomes measured 
included the number of mothers eligible for PPD screening, the actual number of 
mothers who completed screening, and documentation of screening and provision of 
resources and referrals in the EMR.  Demographic information was also collected as 
previously discussed.   
Results 
 After the first PDSA cycle it was determined by the providers, staff, and office 
management that screening at the 9 month and 12 month well-child visits was not 
feasible since an intense infant developmental screen was administered at these visits.  
Therefore, the project was adapted to include PPD screening at the 2 week, 2 month, 4 
month, and 6 month well-child visits.   
 Demographics.  The average age of mothers screened for PPD during the 
project was 28 years.  While the analysis showed that there was an increased risk for 
PPD as the mother’s age decreased, findings suggested that age accounted for only 
3% of the variability in screening positive for PPD.  This is consistent with findings 
by Aasheim et al. (2012) that age is not strong predictor of developing PPD.  One of 
the strongest risk factors for developing PPD is the mother’s history of depression
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during any point in her life and this increases the risk of PPD in all ages (Roy-Byrne, 
2016). 
 Mothers who participated in this project were overwhelmingly Caucasian 
(94%) and although this was determined to be a positive predictor for screening 
positive for risk of PPD, the effect size was very small as previously noted.  Since the 
setting for the project is comprised of primarily Caucasian patients (90%) it is not 
surprising that the majority of mothers screened were also Caucasian.  This finding is 
also not consistent with research indicating that women of all races are at risk for 
developing PPD (National Institute of Mental Health, 2017).  
 The majority (59%) of mothers screened for PPD were married and marital 
status was not identified as a significant predictor for being at risk for PPD.  While 
marital status alone may not be risk factor, mothers who lack emotional support from 
a spouse, partner, family or friends have been shown to have an increased risk for 
PPD (National Institute of Mental Health, 2017).   
 The median age of infants that mothers brought to the office for well-child 
visits during the project was 10.8 weeks, with a range of two to 24 weeks.  Infant age 
was not shown to be a predictor for increasing the risk of mothers developing PPD.  
This is consistent with the findings of Chaudron, Kitzman, Szilagyi, Sidora-Arcoleo 
and Anson (2006) that PPD persists throughout the first year on an infant’s life. 
 The gestational age of infants included in the project ranged from 31 to 41 
weeks with an average age of 38.7 weeks.  Infants born at less than 37 weeks of 
gestation are considered premature.  Analysis from this project demonstrated that 
mothers with infants born at a lower gestational age were at increased risk for 
screening positive for PPD.  Although the effect size was small, this finding is 
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consistent with current findings that premature infants increase the risk of PPD for 
mothers (Wu, Hung & Chang, 2015).   
 Method of feeding was assessed with a majority (60%) being breastfed.  Type 
of feeding was not found to be a predictor of increasing a mother’s risk for PPD.  This 
is consistent with recent findings by Pope, Mazmanian, Bédard, and Sharma (2016) 
which showed that breastfeeding attempt and the duration of breastfeeding is not 
associated with the subsequent development of PPD.   
 Lastly, the type of insurance was also recorded and was predictive of 
screening positive for postpartum depression.  Mothers of infants whose insurance 
was Medicaid were at a higher risk for being positive for PPD.  Although this was a 
significant finding the effect size was small.  However, this is consistent with findings 
described by Earls (2010) that mothers from lower socioeconomic groups report 
higher rates of PPD. 
 EPDS Scores.  During the project, EPDS scores ranged from zero to 21 with a 
mean of 5.3.  Of the 160 mothers screened 16% were identified to be at risk for PPD.  
Although slightly higher, this is still consistent with the prevalence of PPD at the 
national (10-15%), state (12.4%), and local levels (11.5%), (National Institute for 
Healthcare Management, 2010; Ohio Department of Health, 2015).  
 The response to question 10 of the EPDS was recorded separately as this 
question assesses suicidal thoughts and should always be reviewed independently.  
During the project, there were three affirmative responses (1.9%) to this question.  
Each mother responded “sometimes” to this question and when questioned further 
denied active suicidal ideation.  Each mother was also accompanied at the 
appointment by her spouse.  Once the EPDS was reviewed and it was determined that 
the mother was not experiencing active suicidal ideation, the provider remained in the 
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examination room with the mother, spouse, and infant while the mother’s primary 
care provider was contacted and a follow-up appointment was scheduled for that day.  
At no time was the mother left alone.  The mother left the office accompanied by her 
spouse with a follow-up appointment scheduled and resources, including a suicide 
hotline number, provided to her.  The importance of reviewing this question 
separately cannot be overstated as suicide has been identified as the seventh leading 
cause of maternal death (Lewis, et al., 2011). 
 Project Outcomes.  The goal for the project was for 80% of mothers to be 
screened for PPD.  As the run chart demonstrates the median over the 14-week project 
was 67% and the goal of 80% was met or exceeded for four of the 14 weeks.  Several 
factors contributed to not meeting the goal for this project. 
 After the third PDSA cycle it was determined that providing the mother the 
EPDS when she came to the examination room did not allow adequate time to 
complete the screen and for the provider to review the results with her.  Therefore, the 
screen was given to mothers when they came to the front desk to check in for their 
appointment.  This increased the number of screens completed (90%) for the first 
week after implementing this change.  However, with the addition of two providers in 
the next PDSA cycle the number of completed screens dropped below the goal of 
80% again.  Feedback from providers revealed that some mothers were not 
completing the screening and per the project protocol they were not prompting the 
mothers further. 
 Another unforeseen barrier to implementation was the refusal of one provider, 
a pediatric nurse practitioner, who notified the office staff not to provide eligible 
mothers on her schedule with the EPDS.  This provider had verbalized reluctance to 
participate in the project during the initial PDSA cycle and further discussions 
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between the provider, project leader, and officer manager were held.  The results of 
this can be seen during week eight of the project when screening rates decreased to 
50%.  Once the results were reviewed, the office manager met privately with this 
provider and communicated that all providers were expected to implement screening 
at this this time.  This provider began maternity leave the following week and 
remained out of the office for the remainder of the project.  The percentage of mothers 
screened for PPD improved with the absence of this provider, however the percentage 
declined again during this final weeks of the project.   
 There was also a significant decline in completed screens during the final two 
weeks of project implementation.  While reviewing the outcomes from PDSA cycle 9 
it was discovered that the two front desk staff who provided mothers with the EPDS 
had been on vacation on alternate weeks.  The staff member who filled in for these 
individuals was not familiar with the procedure for providing the EPDS to mothers 
when they checked in for their visits.  This resulted in missed opportunities and 
decreased the rate of screening for the final PDSA cycle. 
 There is another factor that may have contributed to not achieving the goal of 
screening 80% of eligible mothers for PPD.  This private pediatric office has a high 
rate (25-30%) of parents who refuse or follow an alternate schedule of vaccinations 
for their children (K. Ely, personal communication, June 12, 2017).  Boom and 
Cunningham (2014) studied parents who delay or refuse vaccines for their children 
and found several common characteristics which include: white race, higher income 
levels, maternal age over 30, and higher educational levels.  These characteristics are 
consistent with the population in this pediatric office and it is possible that these same 
mothers may refuse to complete screening for PPD which will lead to an inability to 
achieve the 80% goal.  
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 Documentation of PPD screening and the provision of resources to mothers in 
the EMR was 100% except for two weeks during the project and this occurred when 
new providers were introduced into a new PDSA cycle.  Because the documentation 
was built into the EMR it was not difficult for providers to complete the required 
documentation and only required reminders while reviewing results of the PDSA 
cycle.   
 Ultimately all providers and staff, except the one provider who refused to 
implement PPD screening, verbalized satisfaction with the screening process and 
were comfortable scoring the EPDS and reviewing the results with mothers.  In 
addition, the office received positive feedback from mothers during the project.  
Mothers who screened positive for being at risk for PPD verbalized gratitude for 
having the opportunity to address their concerns and receive resources and 
information on further evaluation and treatment.  One mother, who screened negative 
for PPD at her infant’s four-month well-child visit, expressed gratitude for being 
screened.  She had been diagnosed and treated for PPD at two months postpartum and 
stated that screening negative at this visit was reassuring that her treatment was 
successful. 
 In addition, the office manager received several phone calls from mothers’ 
primary care providers after they had seen the mothers screened in the office who 
were identified to be at risk for PPD.  These providers were grateful for the 
opportunity to follow-up with these patients and address their concerns. 
Summary of Findings 
 Although this evidence-based practice improvement did not consistently 
achieve the aim for screening 80% of eligible mothers for PPD over the three-and-a-
half-month project period, the project was still considered to be successful by 
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providers, staff, management, and most importantly the mothers who were screened.  
At the conclusion of the project it was decided that the office will continue to screen 
for PPD at the 2 week, 2 month, 4 month, and 6 month visits using the EPDS and 
providing the resources and referrals as implemented throughout the project.  
 Sustaining the practice of screening mothers for PPD at well-child visits was 
considered throughout the development of the project.  First, developing 
documentation of screening and providing resources into the EMR allows providers to 
incorporate this process into their practice without significantly increasing their 
workload.  Secondly, the decision-making algorithm and resources for mothers are 
conveniently located in provider offices so that they can be accessed easily quickly.  
Finally, the office manager will review monthly reports for each provider identifying 
the number of mothers eligible for screening and number of completed screens.  This 
information will be reviewed at monthly provider meetings.  
Lessons Learned & Future Recommendations 
 The importance of clear and consistent communication with office 
management, providers, and staff during the development and implementation of an 
evidence-based practice improvement project cannot be overemphasized.  It is 
through this communication that trust is built and the project is not viewed as merely 
an academic exercise, but rather it is seen as an essential step in improving patient 
outcomes which is the ultimate goal of evidence-based practice. 
 As PPD screening continues in this office it is important to regularly address 
the concerns of providers who verbalize reluctance to screening and to communicate 
expectations clearly.  In addition, as new or temporary staff work in the office it is 
essential that they be aware of office procedures so that this change in practice can be 
sustained. 
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Because the project was implemented in a private pediatric office with an 
overwhelmingly Caucasian patient population, it is unrealistic to assume that the same 
challenges or findings would be similar in a different setting.  Therefore, further 
implementation of PPD screening in diverse settings is recommended.   
Another limitation of the project is the length of time that all providers in the 
office were offering PPD screening to mothers.  It was not until the sixth PDSA cycle, 
which began during week six of the project, that all providers were included in the 
screening process.  By continuing the project for a longer period of time it would have 
been possible to obtain further feedback from providers and make changes to the 
process as indicated.  Ultimately, the results from this project may be useful to 
providers who are interested in establishing PPD screening at well-child visits in 
similar settings.  
Dissemination of Findings 
 The final step of the EBPI model is the dissemination of best practices (Levin 
et al., 2010).  As Betz, Smith, Melnyk and Olbrysh (2015) assert, “new evidence will 
not achieve its maximum value to practice and better patient outcomes unless it is 
communicated effectively” (p. 391). 
 Findings from this project were shared regularly with participants in the 
project during multiple PDSA cycles.  A meeting with the all office members will 
occur after the final defense of the project to review the project outcomes.   
 Further dissemination via poster presentations at relevant professional 
meetings and manuscript submissions to scholarly journals will be actively pursued. 
Conclusion  
PPD and its negative effects on maternal and infant health is well documented.  
Pediatric providers have the most contact with mothers throughout the first year of an 
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infant’s life and therefore have a unique opportunity to intervene by offering frequent 
and consistent screening for PPD.  The implementation of an evidence-based practice 
improvement project at a private pediatric office is a feasible option for identifying 
mothers at risk for PPD, providing them with resources, and referring them to their 
primary care provider for further evaluation and treatment. 
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Appendix A 
Edinburgh Postnatal Depression Scale 
 
 
 
 
 
Edinburgh Postnatal Depression Scale 
1 
(EPDS) 
Name:  ______________________________           Address:  ___________________________ 
Your Date of Birth:  ____________________       ___________________________ 
Baby’s Date of Birth:  ___________________  Phone: _________________________ 
As you are pregnant or have recently had a baby, we would like to know how you are feeling.  Please check 
the answer that comes closest to how you have felt IN THE PAST 7 DAYS, not just how you feel today. 
Here is an example, already completed. 
I have felt happy: 
Yes, all the time 
Yes, most of the time This would mean:  “I have felt happy most of the time” during the past week. 
No, not very often Please complete the other questions in the same way. 
No, not at all 
In the past 7 days: 
1. I have been able to laugh and see the funny side of things *6.  Things have been getting on top of me 
As much as I always could Yes, most of the time I haven’t been able 
Not quite so much now to cope at all 
Definitely not so much now Yes, sometimes I haven’t been coping as well 
Not at all as usual 
2. I have looked forward with enjoyment to things No, I have been coping as well as ever 
As much as I ever did 
Rather less than I used to *7 I have been so unhappy that I have had difficulty sleeping 
Definitely less than I used to Yes, most of the time 
Hardly at all Yes, sometimes 
Not very often 
*3. I have blamed myself unnecessarily when things No, not at all 
went wrong 
Yes, most of the time *8 I have felt sad or miserable 
Yes, some of the time Yes, most of the time 
Not very often Yes, quite often 
No, never Not very often 
No, not at all 
4.    I have been anxious or worried for no good reason 
No, not at all *9 I have been so unhappy that I have been crying 
Hardly ever Yes, most of the time 
Yes, sometimes Yes, quite often 
Yes, very often Only occasionally 
No, never 
*5  I have felt scared or panicky for no very good reason 
Yes, quite a lot *10 The thought of harming myself has occurred to me 
Yes, sometimes Yes, quite often 
No, not much Sometimes 
No, not at all Hardly ever 
Never 
Administered/Reviewed by ________________________________    Date  ______________________________ 
1 
Source: Cox, J.L., Holden, J.M., and Sagovsky, R. 1987.  Detection of postnatal depression: Development of the 10-item 
Edinburgh Postnatal Depression Scale.  British Journal of Psychiatry 150:782-786 . 
2 
Source:  K. L. Wisner, B. L. Parry, C. M. Piontek, Postpartum Depression N Engl J Med vol. 347, No 3, July 18, 2002, 
194-199 
Users may reproduce the scale without further permission providing they respect copyright by quoting the names of the 
authors, the title and the source of the paper in all reproduced copies.
No, most of the time I have coped quite well 
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Agency Permission for Conducting Doctoral Project 
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Appendix C 
Dayton Children’s Hospital IRB Determination Letter 
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Appendix D 
PowerPoint Presentation Handout 
 
SCREENING MOTHERS FOR 
POSTPARTUM DEPRESSION AT 
WELL-CHILD VISITS IN A PRIVATE 
PEDIATRIC CLINIC: AN EVIDENCE-
BASED PRACTICE IMPROVEMENT 
PROJECT
Cassie Fishbein, MS, CPNP
Content
Problem Identification
Purpose and Goals
Guiding Framework
Review of the Literature
Recommendations for Practice Change
Implementation and Evaluation Plan
Summary/Conclusion
Problem Identification
10 to 15% of women suffer from postpartum 
depression (PPD) and symptoms frequently occur 
after hospital discharge and after the postpartum 
check up (Liberto, 2012).
Infants whose mothers have PPD are at greater 
risk for anxiety, depressive and oppositional 
disorders and delayed language development 
(Apter-Levy, et al, 2013).
New mothers and their infants have contact with 
pediatric health care providers at least eight times 
in a child’s first two years if recommended visits 
are completed (Liberto, 2012). 
Purpose
Implement a PPD screening program for 
mothers who bring their infants for well-child 
visits, during the first year of life, at a private 
pediatric practice
Setting and Population
Setting
private pediatric practice in the Midwest located in 
a small town in a rural community
Population
neonates, infants and mothers who present for 
well-child visits at the following scheduled 
intervals: two weeks, two months, four months, 
six months, nine months and 12 months of age
Goals
Identifying mothers at risk for PPD and 
providing them with community resources and 
referrals to their primary care provider for 
further evaluation and treatment
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Appendix E 
Teaching Plan for Staff and Provider Education 
Time 
allowed 
Learning 
outcomes 
Content Methods and 
Materials 
Evaluation 
Method 
45 minutes Describe 
principles of 
EBP 
  
Recognize 
significance of 
PPD and need 
for screening 
 
Describe use of 
EPDS in 
screening for 
PPD 
 
Interpret results 
of EPDS 
Principles of 
EBP 
 
Symptoms of 
PPD 
 
Adverse 
effects of PPD 
on mothers, 
infants and 
families 
 
Use of EPDS 
to screen for 
PPD 
 
Action plan 
for positive 
screening 
result 
 
Resource and 
referral 
options 
Power Point 
presentation 
 
EPDS 
Screening tool 
 
Practice using 
and 
interpreting 
EPDS 
screening 
 
Decision 
making 
algorithm 
 
Community 
resources for 
mothers with 
positive 
screening 
results  
 
 
Discussion 
through Q & 
A 
 
Case study 
 
Role play 
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Appendix F 
Information Letter for Participation in a Quality Improvement Project 
Title: Screening Mothers for Postpartum Depression at Well-Child Visits in a 
Private Pediatric Clinic: An Evidence-Based Practice Improvement Project 
 
Principal Investigator: Cassie Fishbein, MS, CPNP 
Contact Telephone: (937) 272-1965 
 
You are invited to participate in a quality improvement project.  The purpose of 
this project is to screen mothers for postpartum depression (PPD) at well-child visits 
and to provide information and resources to mothers with positive screens for PPD.  
The recognition and treatment of PPD has the potential to benefit mothers, neonates, 
infants and their families.  You were selected as a possible participant because you are 
seeking well-child care for your neonate or infant at Child and Adolescent Specialty 
Care. 
 
What will be involved if you participate? You will be offered to complete a brief, 
10-item depression screen, the Edinburgh Postnatal Depression Scale, when you bring 
your neonate or infant for their 2 week, 2 month, 4 month, and 6 month well-child 
visit.  This self-administered screen, which takes approximately five minutes to 
complete, will be scored and reviewed with you by a pediatric provider.  If the screen 
indicates that a risk for PPD is present, you will be provided with information and 
resources for further evaluation and treatment.   
 
Are there any risks or discomforts? While there are no physical risks associated 
with this screen there is the possibility for emotional discomfort.  Several steps will be 
taken to maintain confidentiality of protected health information.  Random numbers 
will be assigned to replace names and all information will be stored on a flash drive 
and kept in a locked drawer.  The investigator will be the only person with access to 
this information.  There may be other risks which are unknown at this time. 
 
Are there any benefits to yourself or others? Identifying PPD can lead to further 
evaluation and treatment.  This has the potential to benefit not only you but your 
neonate, infant and family.  PPD can lead to negative effects for children including 
anxiety, depression and oppositional conduct disorders, and delayed language 
development.  Early recognition and treatment can reduce these effects. 
 
Are there any costs? There are no costs to you for participating in this project.  You 
will not receive financial compensation for your participation.  
 
What other options are there? You may choose not to participate in this project. 
 
Can you change your mind? Your participation is completely voluntary and you 
may withdraw from the project at any time by sending written notice to the principal 
investigator, Cassie Fishbein at http://fishbein.2@wright.edu.  Your decision about 
whether or not to participate will not jeopardize your future relations with Child and 
Adolescent Specialty Care.  
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The information about you collected for this research will be protected by 
removing any patient or participant identifiers once data collection is complete.  All 
study information will be stored in secured research files on a flash drive and 
identified by a code number.  The principal investigator will have access to your 
protected health information.  If results of this project are reported in journals, at 
scientific meetings, or used for educational purposes, the people who participated in 
this project will not be identified. 
 
If you have questions about this project please ask them now or you may contact 
the principal investigator at (937) 272-1965. 
 
HAVING READ THE INFORMATION PROVIDED, IT IS YOUR CHOICE TO 
DECIDE IF YOU WANT TO PARTICIPATE IN THIS QUALITY 
IMPROVEMENT PROJECT. IF YOU DECIDE TO PARTICIPATE, THE CHOICE 
TO COMPLETE THE EDINBURGH POSTNATAL DEPRESSION SCALE WILL 
SERVE AS YOUR AGREEMENT TO DO SO.   
 
THIS INFORMATION LETTER IS YOURS TO KEEP. 
 
 
_______________________________________ 
Principal Investigators Signature and Date 
 
_______________________________________ 
Print Name and Date 
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Appendix G 
Postpartum Support International (PSI) Brochure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Postpartum Support International 
6706 SW 54th Avenue 
Portland, OR  97219 
Office: (503) 894-9453 
Fax: (503) 894-9452 
www.postpartum.net 
 
Brochures available  in  English  &  Español 
Find them  at w w w .postpartum .net/resources  
THINGS YOU CAN DO 
Being a good parent includes taking care 
of yourself. If you take care of yourself, 
you will be able to take better care of your 
baby and your family. 
• Talk to a counselor or healthcare provider 
who has training in perinatal mood and 
anxiety problems. 
 
• Learn as much as you can about 
pregnancy and postpartum depression 
and anxiety. 
 
• Get support from family and friends. 
Ask for help when you need it. 
 
• Join a support group in your area or 
online. 
 
• Keep active by walking, stretching or 
whatever form of exercise helps you to 
feel better. 
 
• Get enough rest and time for yourself. 
 
• Eat a healthy diet. 
 
• Don’t give up! It may take more than 
one try to get the right help you need. 
 
• Call or email us; we will help you. 
•  
 
www.postpartum.net 
HOW ARE YOU FEELING NOW? 
While many women experience some mild 
mood change or “the blues” during or 
after the birth of a child, 1 in 7 women 
experience more significant symptoms of 
depression or anxiety. 1 in 10 Dads 
become depressed during the first year. 
 
PARENTS: 
Are you feeling sad or depressed? 
Is it difficult for you to enjoy yourself? 
Do you feel more irritable or tense? 
Do you feel anxious or panicky? 
Are you having difficulty bonding 
with your baby? 
Do you feel as if you are "out of control" 
or "going crazy”? 
Are you worried that you might hurt 
your baby or yourself? 
 
FAMILIES: 
Do you worry that something is wrong 
but don’t know how to help? 
Do you think that your partner 
or spouse is having problems 
coping? 
Are you worried that it may never 
get better? 
 
Any parent can suffer from pregnancy or 
postpartum mood or anxiety disorders. 
However, with informed care you can prevent 
a worsening of symptoms and can fully 
recover. It is essential to recognize symptoms 
and reach out as soon as possible so that 
you can get the help you need and deserve. 
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Appendix H 
Many Shades of Blue Brochure 
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Appendix I 
Decision Making Algorithm 
 
 
 
 
Mother 
Provided 
EPDS 
Mother 
Completes 
EPDS 
EPDS Scored 
by Provider 
EPDS < 
10 
EPDS ≥ 
10 
EPDS + 
for #10 
Discuss 
Results with 
Mother 
Document 
in EMR 
Discuss 
Results with 
Mother 
Refer mother to 
her PCP and 
provide 
resources  
Document 
in EMR 
Do not leave 
mother and 
infant alone 
Contact 
911 
Document 
in EMR 
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Appendix J 
Institute for Healthcare Improvement PDSA Worksheet 
 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: (overall goal you wish to achieve) 
 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to 
be done 
Where to 
be done 
    
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to 
be done 
 
 
 .  
 
Predict what will happen when the test is carried 
out 
Measures  to determine if prediction succeeds 
   
Do  Describe what actually happened when you ran the test 
 
 
 
Study Describe the measured results and how they compared to the predictions 
 
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned   
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Appendix K 
PDSA Cycles 1- 9 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Providers and office staff will gain knowledge regarding EBPI, screening for PPD, and use of the EPDS 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Initial introduction of the project to providers and staff DNP student 2/6/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Prepare PowerPoint presentation 
Prepare handouts including EPDS and community resources 
Coordinate meeting times with office manager 
DNP student .Jan 2017 DNP student 
home office 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers and staff will receive information regarding the EBPI 
process, the project, and gain competence in using the EPDS to 
screen for PPD 
Providers and staff verbalize understanding of the EPBI process and 
project 
Provider and staff demonstrate competence in administering and 
scoring EPDS 
Do  Describe what actually happened when you ran the test 
  Presentation and practice with administering and scoring EPDS were completed as planned. Providers and staff verbalized concern that 
administering the EPDS at the 9-month and 12-month well-child visits would be impractical as time-intensive infant developmental screening occurred at these 
visits.  Two providers verbalized reluctance to implement the project as the mother was not the patient of the practice and they were concerned with legal 
implications. 
 
 
Study  Describe the measured results and how they compared to the predictions 
  With the exception of two providers, there was enthusiasm about implementation of the project.  All providers and staff verbalized an 
understanding of the EBPI process and project.  All providers and staff demonstrated how to administer and score the EPDS. 
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  Because of the infant developmental screens administered at the 9-month and 12-month well-child visits, it was decided to implement PPD 
screening at the 2-week, 2-month, 4-month, and 6 month well-child visits.  Additional meetings with the two providers who expressed concerns about the project 
were held with the DNP student and office manager on 2/10/17. 
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PDSA Cycle 2 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Implement screening for PPD with two providers at 80% of eligible visits for one week 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Implementation of PPD screening with two providers for one week DNP student 
CPNPs 
3/6/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review screening procedure, available resources, and appropriate documentation 
with providers 
 
Create documentation for PPD screening within the EMR 
 
Review results with providers and office manager 
DNP student 
 
 
DNP student and 
CPNP 
 
DNP 
student/office 
manager and 
providers 
3/6/17 
 
 
3/6/17 
 
 
3/10/17 
office 
 
 
office 
 
 
office 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
Documentation of screening will be created in the EMR 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  After reviewing materials with the providers and creating documentation within the EMR, PPD screening was implemented for one week.  Data 
was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  Two mothers were identified as eligible to screen during this time and both screens were completed.  Documentation in the EMR was completed 
for all screens.  Providers verbalized confidence in scoring and reviewing the results with mothers in a timely manner.  Results were reviewed with the providers 
and the office manager. 
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  Implementation of the project to continue with the addition of a provider in the next week. 
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PDSA Cycle 3 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with additional provider (three total) at 80% of eligible visits for two weeks 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with the addition of additional provider  DNP student 
CPNPs 
MD 
3/13/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review screening procedure, available resources, and appropriate documentation 
with provider who will begin screening 
 
Review results with providers and office manager 
DNP student and 
MD 
 
DNP 
student/office 
manager and 
providers 
3/13/17 
 
 
3/24/17 
 
office 
 
 
office 
 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  After reviewing materials with the additional provider, PPD screening continued for two weeks.  Data was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  Ten mothers were identified as eligible to screen and two screens were completed. Documentation in the EMR was completed for all screens.  
Providers verbalized confidence in scoring and reviewing the results with mothers in a timely manner.  Results were reviewed with the providers and the office 
manager.  The providers believed that providing the EPDS to the mother when she came to the exam room did not allow adequate time for the screen to be 
completed, scored, and reviewed during the visit.  
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  The EPDS will be given to the mother at check-in to allow further time for completion.  Implementation of the project to continue with the addition 
of a provider in the next cycle.   
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PDSA Cycle 4 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with additional provider (four total) at 80% of eligible visits for one week 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with the addition of additional provider  
Provide mother with EPDS at check-in 
DNP student 
CPNPs 
MDs 
3/27/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review screening procedure, available resources, and appropriate documentation 
with provider who will begin screening 
 
Discuss changes with staff and provide EPDS to mothers at check in 
 
Review results with providers and office manager 
DNP student and 
MD 
 
DNP student 
 
DNP 
student/office 
manager and 
providers 
3/27/17 
 
 
3/27/17 
 
3/31/17 
 
office 
 
 
office 
 
office 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
Number of completed screens will increase by providing the EPDS to 
mothers at check-in 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  After reviewing materials with the additional provider, PPD screening continued for one week.  Discussions were held with staff regarding the 
change of providing the EPDS to mothers at check-in.  Data was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  Ten mothers were identified as eligible to screen and nine screens were completed. Documentation in the EMR was completed for seven 
screens.  Results were reviewed with the providers and the office manager.  The providers believed that providing the EPDS to the mother when she came to the 
exam room increased the likelihood of the screen being completed and facilitated the review and scoring of the EPDS in a timely manner.  
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  The EPDS will continue to be given to the mother at check-in.  Implementation of the project to continue with the addition of two providers in the 
next cycle.   
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PDSA Cycle 5 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with additional providers (six total) at 80% of eligible visits for two weeks 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with additional providers  
 
DNP student 
CPNPs 
MDs 
4/3/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review screening procedure, available resources, and appropriate documentation 
with providers who will begin screening 
 
Review results with providers and office manager 
DNP student and 
MD 
 
DNP 
student/office 
manager and 
providers 
4/3/17 
 
 
4/14/17 
 
office 
 
 
office 
 
 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  After reviewing materials with the additional provider, PPD screening continued for two weeks.  Data was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  34 mothers were identified as eligible to screen and 21 screens were completed. Documentation in the EMR was completed for 18 screens.  
Results were reviewed with the providers and the office manager.  Providers stated that some mothers were not completing the screens and per the project 
protocol they were not prompting them further.  The providers also stated that they were receiving positive feedback about the screening from mothers who 
completed the EPDS.  All providers felt confident in scoring and reviewing the EPDS with mothers.   
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  Implementation of the project to continue with the addition of two providers in the next cycle, which will include all providers in the practice.   
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PDSA Cycle 6 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with additional providers (eight total) at 80% of eligible visits for two weeks 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with the addition of two providers 
 
DNP student 
CPNPs 
MDs 
4/17/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review screening procedure, available resources, and appropriate documentation 
with providers who will begin screening 
 
 
Review results with providers and office manager 
DNP student  
MD 
CPNP 
 
DNP 
student/office 
manager and 
providers 
4/17/17 
 
 
4/28/17 
 
office 
 
 
office 
 
 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  After reviewing materials with the additional providers, PPD screening continued for two weeks.  All providers in the office will be involved in the 
project at this time.  Data was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  52 mothers were identified as eligible to screen and 33 screens were completed. Documentation in the EMR was completed for all screens.  
Results were reviewed with the providers and the office manager and it was discovered that one of the providers had communicated to staff not to provide eligible 
mothers with the EPDS as she was not comfortable with screening and would be out on maternity leave within the next few weeks.  All other providers felt 
confident in scoring and reviewing the EPDS with mothers and stated that they continued to receive positive feedback from mothers who were screened.     
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  Implementation of the project to continue with all providers screening in the next cycle.  The office manager met privately with the provider who 
refused to screen on 4/28/17 and communicated that all providers were expected to implement screening at this time.   
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PDSA Cycle 7 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with all providers at 80% of eligible visits for two weeks 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with all providers participating 
 
DNP student 
CPNPs 
MDs 
5/1/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review results with providers and office manager DNP 
student/office 
manager and 
providers 
5/1/17 
 
 
5/12/17 
 
office 
 
 
office 
 
 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  All providers are involved in the project at this time.  Data was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  37 mothers were identified as eligible to screen and 30 screens were completed. Documentation in the EMR was completed for all screens.  
Results were reviewed with the providers and the office.  All other providers felt confident in scoring and reviewing the EPDS with mothers and stated that they 
continued to receive positive feedback from mothers who were screened.  There was on mother who responded yes to question 10 on the EPDS.  The response 
was “sometimes” to the question of self-harm.  The mother was accompanied by her spouse and the mother’s primary-care giver was contacted while the provider 
was in the exam room and a follow-up appointment was scheduled for the following day.  The mother left the office with resources, accompanied by her spouse, 
and with instructions on seeking emergency care as indicated.  The provider who refused to screen was out on maternity leave effective 5/1/17.   
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  Implementation of the project to continue with all providers screening in the next cycle.   
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PDSA Cycle 8 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with all providers at 80% of eligible visits for two weeks 
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with all providers participating 
 
DNP student 
CPNPs 
MDs 
5/15/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review results with providers and office manager DNP 
student/office 
manager and 
providers 
5/26/17 
 
office 
 
 
 
 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  All providers are involved in the project at this time.  Data was collected by retrospective chart review.   
 
 
Study  Describe the measured results and how they compared to the predictions 
  61 mothers were identified as eligible to screen and 42 screens were completed. Documentation in the EMR was completed for all screens.  
Results were reviewed with the providers and the office manager.  The office manager has received feedback from an ob/gyn office stating that one of their 
patients was screened at the office and was seen for follow-up by them.  They expressed gratitude that our office was offering PPD screening.  There was on 
mother who responded yes to question 10 on the EPDS.  The response was “sometimes” to the question of self-harm.  The mother was accompanied by her 
spouse and the mother’s primary-care giver was contacted while the provider was in the exam room and a follow-up appointment was scheduled for the following 
day.  The mother left the office with resources, accompanied by her spouse, and with instructions on seeking emergency care as indicated.  All providers 
expressed satisfaction with the screening process.   
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  Implementation of the project to continue with all providers screening in the next cycle.   
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PDSA Cycle 9 
 
PDSA Worksheet for Testing Change 
Institute for Healthcare Improvement 
 
Aim: Continue screening for PPD with all providers at 80% of eligible visits for two weeks.  
   Every goal will require multiple smaller tests of change 
Describe your first (or next) test of change:  Person 
responsible 
When to be 
done 
Where to be 
done 
Continuation of PPD screening with all providers participating 
 
DNP student 
CPNPs 
MDs 
5/30/17 office 
Plan   
List the tasks needed to set up this test of change Person 
responsible 
When to 
be done 
Where to be 
done 
Review results with providers and office manager 
Review project outcomes and plans for sustainability 
DNP 
student/office 
manager and 
providers 
6/9/17 
 
office 
 
 
 
 
 
Predict what will happen when the test is carried out Measures to determine if prediction succeeds 
 Providers will screen for PPD, document results, and provide 
appropriate resources/referrals at greater than or equal to 80% of 
eligible well-child visits 
 
Screening for PPD will continue after completion of the project 
Number of eligible mothers screened will be compared to actual 
number of mothers screened 
 
Documentation of results and appropriate resources/referrals in the 
EMR 
Do  Describe what actually happened when you ran the test 
  All providers are involved in the project at this time.  Data was collected by retrospective chart review.  Project outcomes were reviewed with all 
providers and the office manager.  Plans for sustaining PPD screening were discussed. 
 
 
Study  Describe the measured results and how they compared to the predictions 
  49 mothers were identified as eligible to screen and 21 screens were completed. Documentation in the EMR was completed for all screens.  
Results were reviewed with the providers and the office manager.  During this cycle the two front desk staff were on vacation on alternate weeks.  The person who 
filled in for them was not familiar with giving eligible mothers the EPDS to complete which resulted in fewer mothers having the opportunity to complete the screen.  
There was on mother who responded yes to question 10 on the EPDS.  The response was “sometimes” to the question of self-harm.  The mother was 
accompanied by her spouse and the mother’s primary-care giver was contacted while the provider was in the exam room and a follow-up appointment was 
scheduled for the following day.  The mother left the office with resources, accompanied by her spouse, and with instructions on seeking emergency care as 
indicated.  While reviewing preliminary project outcomes with providers, the office manager, and staff, it was agreed unanimously to continue offering PPD 
screening in the office.  The office manager had already spoken with the provider who had refused to screen earlier in the project and established clear 
expectations moving forward. 
 
 
Act  Describe what modifications to the plan will be made for the next cycle from what you learned  
  PPD screening to continue with all providers as established in the project. 
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Appendix L 
Data Collection Tool 
 
Data Collection Tool (Retrospective) 
 
Client 
number 
Date 
of 
Visit 
Age Race G P Marital 
Status 
Years 
of 
School 
Method 
of 
Infant 
Feeding 
Completed 
Weeks of 
Gestation 
Insurance 
Type 
Result of 
Screening 
(+/-) 
Documentation 
of Review of 
Screening 
(Y/N) 
Documentation of 
Resources/Referral 
Provided 
(Y/N) 
1           (+/-) (Y/N) (Y/N) 
2           (+/-) (Y/N) (Y/N) 
3           (+/-) (Y/N) (Y/N) 
4           (+/-) (Y/N) (Y/N) 
5           (+/-) (Y/N) (Y/N) 
6           (+/-) (Y/N) (Y/N) 
7           (+/-) (Y/N) (Y/N) 
8           (+/-) (Y/N) (Y/N) 
9           (+/-) (Y/N) (Y/N) 
10           (+/-) (Y/N) (Y/N) 
11           (+/-) (Y/N) (Y/N) 
12           (+/-) (Y/N) (Y/N) 
13           (+/-) (Y/N) (Y/N) 
14           (+/-) (Y/N) (Y/N) 
15           (+/-) (Y/N) (Y/N) 
 
